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Abstract 
Ageing results in a progressive decline in all organ systems throughout the 
body. This is particularly evident in the musculature, where it can manifest as 
sarcopenia, the loss of muscle mass and strength. At the molecular level, ageing is 
often accompanied by a decline in muscle structure and function, as well as 
alterations in muscle proteostasis and metabolism. MicroRNAs (miRNAs) are small 
22-26 nucleotide RNAs that bind with complementarity through their seed sequence 
to target mRNAs to downregulate gene expression. They can work as molecular 
switches or fine tune gene regulation through feedback, and typically have multiple 
targets, thereby coordinating cellular programs. As miRNAs could serve as 
therapeutic targets and are shown to be regulated with age, it would be of interest to 
investigate whether miRNAs can influence ageing parameters.  Mir-1 is a muscle 
enriched microRNA highly conserved in evolution and is essential to mammalian 
muscle and heart function. However, elevated mir-1 levels are associated with 
muscle dysfunction and disease, suggesting a possible pleiotropic effect of mir-1 
during the ageing process. Mir-1 mouse knockouts, however, are lethal and therefore 
difficult to study. By contrast, C. elegans mir-1 deletion mutants are viable, making it 
an ideal model organism to study the function of mir-1 in muscle ageing.  
In this work I focused on the potential role of mir-1 in regulating muscle 
function, proteostasis and organismal ageing. I found that mir-1 null mutations 
alleviate some of the known ageing-related symptoms: mir-1 null animals have 
increased motility, reduced aggregate formation under proteotoxic challenge, and 
show enhanced autophagy and lysosomal function. I subsequently identified 
lysosomal v-ATPase subunits and daf-16 as strong candidates for mediating the 
effect of mir-1 through proteomics- and bioinformatics-based screens. Follow-up 
experiments revealed that mir-1 downregulates VHA-13, a subunit of the lysosomal 
v-ATPase, in the muscle of C. elegans.  It is likely that mir-1 directly suppresses vha-
13 mRNA translation through its binding to homologous sequences in the 3´UTR. 
Interestingly, I also identified mir-1-dependent effects outside of the muscle, such as 
increased lysosomal acidification in the gut of mir-1 mutants. This suggests potential 
non-tissue autonomous regulation by mir-1. In agreement with this observation I 
provided evidence that mir-1 is present in the circulation of Drosophila and possibly 
reaches target tissues. Elucidating, whether and how mir-1 could affect gene 
expression in tissues other than its site of expression could open up an interesting 
new field of research.  
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In summary, this study reveals that muscle expressed mir-1 impacts 
organismal function, and implies both cell autonomous and non-autonomous control. 
Zusammenfassung 
Altern ist ein komplexer Prozess, bei dem die Funktion aller Organsysteme des 
Körpers zunehmend beeinträchtigt werden. Solche altersbedingten Funktionsverluste 
lassen sich in der Muskulatur besonders gut beobachten, wo sie sich als Sarkopenie, 
also dem vorschreitenden Abbau von Muskelmasse und dem Abnehmen der 
Muskelkraft, manifestieren. Auf dem zellulären und molekularen Niveau geht dies oft 
mit Beeinträchtigung der Muskelstruktur und -funktion einher, und auch mit der 
Veränderung der Eiweisshomöostase (Proteostase) und des Stoffwechsels. Trotz 
dieser oft umfangreichen Umgestaltung zeigt die Muskultur jedoch auch noch im 
hohen Alter ein hohes Maß an Plastizität und kann positiv auf Training und Belastung 
reagieren und sich regenerieren. Darüber hinaus sind die positiven Effekte des 
Muskeltrainings häufig auch in anderen Organsystemen zu sehen, was darauf 
hinweist das die Muskulatur eventuell auch andere Gewebe in einer nicht-
zellautonomen Weise beeinflusst. Trotz dieser interessanten Rolle, welche die 
Muskulatur im Alterungsprozesses innehat, ist es jedoch unklar welche molekularen 
Mechanismen für die Veränderungen verantwortlich sind. MicroRNAs (miRNAs) sind 
kleine RNA Moleküle die durch Sequenzkomplementarität an mRNAs binden und 
dadurch die Exprimierung der entsprechenden Gene senken. miRNAs können als 
molekulare Schalter fungieren, haben oft mehrere Zielgene, und können diese durch 
Rückkopplungsmechanismen präzise regulieren, wodurch sie zur Koordination von 
zellulären Programmen gut geeignet sind. Da miRNAs durch Pharmazeutika reguliert 
werden können und ihre Exprimierung sich im Altern quantitativ verändert, wollten 
wir wissen ob diese Moleküle auch den Alterungsvorgang beeinflussen. Mir-1 ist eine 
miRNA die in der Muskulatur angereichert ist, evolutionär konserviert ist und in 
Säugetieren für Muskel- und Herzfunktion unerlässlich ist. Andererseits sind erhöhte 
Mengen an mir-1 mit Muskelfehlfunktionen assoziiert, was auf eine pleiotrope 
Wirkung von mir-1 im Altern hinweist. Knockout-Mäuse bei denen das mir-1 Gen 
fehlt, sind nicht lebensfähig, und dadurch schwer zu untersuchen. C. elegans 
Fadenwürmer mit einer mir-1 Deletion sind jedoch lebensfähig, und sind dadurch ein 
gutes Model um die Rolle von mir-1 im alternden Muskel zu studieren.  
Fokus der hier vorgelegten Arbeit war es die mögliche Rolle von mir-1 bei der 
Regulierung von Muskelfunktion, Proteostase und Alterungsprozessesen zu 
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entschlüsseln. Dabei konnte ich nachweisen, dass mehrere altersbedingten 
Symptome bei Fadenwürmern ohne funktionsfähiges mir-1 reduziert zu beobachten 
sind. So haben diese Tiere zum Beispiel erhöhte Beweglichkeit, formen weniger 
Aggregate bei proteotixischem Stress, und zeigen gesteigerte autophagische und 
lysosomale Aktivität. Mittels Proteomanalyse und Bioinformatik konnte ich 
ausserdem mehrere lysosomalen v-ATPase Untereinheiten und daf-16 als 
Kandidaten identifizieren, die den Effekt von mir-1 vermitteln könnten. In 
Folgeexperimenten konnte ich belegen, dass mir-1 die Menge der lysosomalen v-
ATPase Untereinheit VHA-13 im Muskel von C. elegans reduziert. Des Weiteren 
konnte ich zeigen, dass diese Regulierung wahrscheinlich durch das direkte Binden 
von mir-1 an Zielsequenzen in dem 3‘ untranslatiertem Bereich von vha-13 erfolgt. 
Interessanterweise zeigten meine Experimente auch mir-1-abhängige Regulierung 
außerhalb der Muskulatur, so zum Beispiel war erhöhte Versäuerung der Lysosomen 
im Darm von mir-1 Mutanten zu messen. Dies deutet darauf hin, dass mir-1 eventuell 
auch nicht-zellautonome Funktionen ausüben könnte. In Übereinstimmung mit dieser 
Hypothese konnte ich mir-1 Moleküle in der Hämolymphe von Drosophila 
melanogaster nachweisen. 
Zusammenfassend konnte ich belegen, dass die in der Muskulatur exprimierte mir-1 
microRNA mehrere Merkmale des Alterungsvorgangs beeinflusst, und konnte sowohl 
Gene identifizieren, welche diesen Effekt vermitteln könnten, als auch eine mögliche 
nicht-zellautonome Funktion von mir-1 nachweisen.  
 
 
 
 
 
 
 
 
 
 
 
 
 8 
Abbreviations 
AD  Alzheimer ́s disease 
AGO 2  argonaute 2 
AMPK  AMP-activated proteinkinase 
Aß amyloid-beta 
ATG                                            autophagy-related  
ATP  adenosine triphosphate 
ATPase  adenosintriphosphatase 
BDNF brain-derived neutrophic factor 
bp                                          basepair 
C. elegans                                     Caenorhabditis elegans 
cDNA                                           complementary DNA 
CMA chaperone-mediated autophagy 
CR caloric restriction 
CRISPR                                clustered regularly interspaced short palindromic repeats 
DAF                                               abnormal dauer formation 
DAF-2  C. elegans homolog of mammalian IRS-1R 
DAF-16  C. elegans homolog of mammalian FOXO 
Drosophila  Drosophila melanogaster  
dsRNA                                          double-stranded RNA 
ER                                              endoplasmatic reticulum 
ETC electron transport chain 
FOXO  forkhead box class O 
GFP    green fluorescent protein 
HD  Huntington ́s disease 
HDL high-density lipoproteins 
HLH-30  helix loop helix 30 
HSP-70  heat-shock protein 70 
HSR  heat shock response 
IGF-1                                           insulin-like growth factor 1  
IRS-1  insulin-receptor-substrate 1 
KD Knock-down 
KO                                               knock-out 
LAMP2a  lysosome-associated membrane protein 2a 
Lc3  light chain 3 
LIR LC3-interacting regions 
LMP-1  LAMP (lysosome-associated membrane protein) homolog 
MEF-2  myogenic transcription factor 2 
mir-1                                             MicroRNA-1 
 9 
miRNA                                          MicroRNA         
mRNA                                          messenger RNA 
mTOR                                         mammalian target of rapamycin 
mTORC1  mammalian target of rapamycin complex 1 
OE  overexpression 
PBS                                           phosphate-buffered saline 
PCR                                          polymerase chain reaction 
PFA                                          paraformaldehyde DAPI 4′,6-diamidino-2-phenylindol  
poly Ub polyubiquitin 
polyQ                                       polyglutamine 
PQC  protein Quality Control 
PTM  posttranslational modification 
PTM  posttranslational modification 
RISC RNA-induced silencing complex 
RNAi                                         RNA interference 
RT                                              room temperature 
RT-qPCR                                  quantitative real-time PCR 
S. cervisiae  Saccharomyces cervisiae 
SDS  sodium dodecyl sulfate 
siRNA  small interference RNA 
snoRNA                                small nucleolar RNA  
ssRNA                                          single-stranded RNA 
TFEB                                          transcription factor EB 
UB  ubiquitin 
Unc  uncoordinated 
UPR  unfolded protein response 
UPR                                           unfolded protein response 
UPRER unfolded protein response endoplasmatic reticulum  
UPRmt unfolded protein response mitochondrial 
UPS                                           ubiquitin–proteasome system  
UTR                                          untranslated region 
v-ATPase  vacuolar ATPase 
VHA Vacuolar H ATPase 
XBP-1                                          X-box binding protein 1 
XBP1s  spliced XBP1 
YFP     yellow gluorescent protein 
Zyx-1  zyxin-1 
α alpha 
β beta 
° degree 
μ micro 
  
 
 10 
1 Introduction  
1.1 Ageing 
 
1.1.1 Human Life Expectancy  
 
Improvements in public health and medicine have led to a remarkable increase in 
human life expectancy across the world. For example, global average life expectancy 
increased by 5.5 years between 2000 and 2016, the fastest increase since the 1960s 
(WHO, Global Health Observatory (GHO) data, 2018). Furthermore, by 2050, one in 
six people in the world will be over the age of 65 (16%), as compared to one in 11 in 
2019 (9%) (World Population Prospects: The 2017 Revision, United Nations). 
The down side of this achievement is that many of the elderly experience 
age-associated disease. The healthy life expectancy (HALE) is calculated by the 
WHO to be 71.6 years (WHO, Global Health Observatory (GHO) data, 2018), which 
gives a period of around 10 years in which the elderly person will encounter various 
age-related diseases. This has been accompanied by demographic changes in which 
an ever-greater proportion of the population is elderly (World Population Prospects: 
The 2015 Revision, United Nations). These developments are not only a burden for 
individuals and their families, but also put increasing pressure on the health care 
sector and governments. In particular, age-associated neurodegenerative diseases 
like Alzheimer´s disease (AD) currently have no viable treatment (Bulck et al. 2019). 
Current worldwide number of patients is estimated at 46.8 million patients living with 
dementia in 2015, with projected increases up to 131.5 million patients by 2050 
(World Alzheimer Report 2019, Alzheimer´s Disease International). This is a serious 
issue that must be dealt with now, and research on ageing and dementia is essential 
to increase healthspan of the growing population of elderly people.  
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Figure 1. Global ageing will accelerate in coming decades. In 2015, 12 per cent of the 
global population, or 901 million people, were aged 60 or over. The number of older persons 
is growing at an annual rate of 3.3 per cent, faster than any other age group. Due to a 
projected overall reduction in fertility, population ageing will continue at high levels globally, 
and by 2050, 22 per cent of the total population, or 2.1 billion persons, will be aged 60 or 
over. Currently, Europe has the highest percentage of population aged 60 or over (24 per 
cent), but rapid ageing will occur in other parts of the world as well. All major areas of the 
world, except for Africa, will have nearly a quarter or more of their populations aged 60 or 
over by 2050. Data source. United Nations, Department of Economic and Social Affairs, 
Population Division (2015). World Population Prospects: The 2015 Revision. 
  
1.1.2 Ageing 
 
Ageing is a complex process and is usually defined as a gradual loss of physiological 
functions in combination with reduced fertility and increased mortality. Understanding 
the forces of why we age and how we can modulate the ageing process is an 
important field of research as ageing is accompanied by decreased fitness and by a 
strongly increased risk for severe diseases. Fitness is under evolutionary selection 
as it determines the changes to reproduce. However, accumulation of late-acting 
mutations could be under the so-called ‘selection shadow’ and are not selected 
against. Furthermore, pleiotropic genes that benefit organisms early in life will be 
favored by selection even if they might be deleterious post-reproductively (Kirkwood 
and Austad 2000). Even though environmental factors can influence the ageing 
process, I will highlight the genetic basis underlying longevity and the ageing process 
in the following paragraph. 
López-Otín and colleagues ascribed the decline of physiological functions that occur 
during ageing into specific molecular hallmarks of ageing (López-Otín et al. 2013). 
These hallmarks include genomic instability, telomere attrition, epigenetic alterations, 
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loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular 
senescence, stem cell exhaustion, and altered intercellular communication. The 
underlying cause of each hallmark in particular and the ageing process in general is 
hypothesized to be the time-dependent accumulation of molecular damage. The 
interconnectedness of the hallmarks and their individual contribution to the ageing 
phenotype is still under investigation. Obviously, interventions that enhance health 
and lifespan are the most informative about the ageing process, and much of the 
current ageing research aims to show that amelioration of single hallmarks or the 
combination of hallmarks improves lifespan.  
 Interestingly, single-gene mutations were discovered who could stave off the 
ageing process and delay many of the hallmarks of ageing at once.  
 
 
Figure 2. The hallmarks of ageing. These hallmarks shown in this scheme include genomic 
instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient 
sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered 
intercellular communication (López-Otín et al. 2013). 
 
1.1.3 Insulin-IGF-signaling 
 
One well-established example is the missense mutation in the daf-2 insulin receptor 
in C. elegans which extended animal lifespan by 200% (Kenyon et al. 1993). 
Importantly, daf-2, not only extends life span but also delays the onset of age-
associated functional decline and confers resistance to pathogens (Halaschek-
Wiener et al. 2005). Later it was found that this same signalling pathway regulates 
life span across taxa (Clancy et al. 2001) (Tatar et al. 2001) (Blüher et al. 2013) 
(Bonafè et al. 2003). Interestingly, this lifespan extension by daf-2 mutation can be 
fully suppressed by inhibition of the Fork head transcription factor DAF-16 (Kenyon et 
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al. 1993) (Ogg et al. 1997) (Larsen et al. 1995). Furthermore, several longevity 
pathways like mTOR and AMPK signaling impinge on DAF-16 (Robida-Stubbs et al. 
2012) (Greer et al. 2008), making DAF-16 a key transcription factor that integrates 
different signals from these pathways to modulate aging, and longevity via shuttling 
from cytoplasm to nucleus. DAF-16 participates in a wide range of important cellular 
processes such as cell cycle arrest, apoptosis, and metabolism besides its function 
in stress resistance and longevity (A. D and Kc 2004). Understanding how these 
longevity genes orchestrate is of paramount importance to understand the process of 
ageing on an organismal, but also on tissue level.  
 
1.1.4 Muscle ageing 
 
Ageing is a segmental process and not all tissues undergo ageing at the 
same rate. In particular, muscle ageing is associated with gradual subcellular 
changes and the effect of functional loss of muscle tissue is impacting physical 
performance and overall health, and is observed in ageing animals across taxa. 
Recently, a single gene was discovered in C. elegans, called unc-120, which delays 
muscle ageing and thereby greatly improves health span of the worms. Interestingly, 
this gene does not extend maximum lifespan, uncoupling healthspan from lifespan 
(Mergoud, Molin, and Solari 2014). 
In fact, staying active throughout life increases general health and improves 
healthy ageing. Good functioning of skeletal, as well as cardiac muscle, is essential 
for proper movement and maintaining activity during ageing. Sarcopenia is among 
the most prevalent age-associated muscle disease. Muscle strength slowly declines 
every decade until the age of 70, where after muscle strength falls off precipitously 
(Siparsky, Kirkendall, and Garrett 2014). One reason for this decline in muscle mass 
could be the general decrease of muscle proteins with ageing (Mergoud, Molin, and 
Solari 2014) (Ayyadevara et al. 2016). Muscle tissue undergoes constant remodeling 
during exercise and needs to compensate for high levels of oxidative stress as well 
as tissue damage. Muscle health is therefore expected to be highly reliant on 
processes such as protein synthesis, folding, and degradation, i.e. proteostasis (see 
below), and reflects a lifetime of continuous mechanical and metabolic stress. Thus, 
the age-dependent decline in proteostasis (as described in the "hallmarks of 
ageing"), unfortunately leads to increased accumulation of misfolded proteins in 
skeletal, as well as cardiac muscle, causing functional decline (Ayyadevara et al. 
2016). It is widely accepted that physical activity and moderate exercise are essential 
for muscle health and healthy ageing (Harber et al. 2009) (Nascimento et al. 2019) . 
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By inference, exercise leads to improvements in muscle proteostasis (Campos et al. 
2018) (Masiero et al. 2009) (Park 2019). Therefore, it is important to understand how 
to maintain muscle strength into older age, and find novel interventions to improve 
proteostasis and prevent protein aggregation in the ageing muscle. 
Figure 3. Muscle functional decline during ageing can be modulated by exercise. 
Muscle ageing is associated with a loss of muscle stem cells (satellite cells), decrease in 
mitochondrial number and abnormal morphology and function, lower levels of autophagy and 
a decrease in myokine secretion (left picture). Data source: 
https://myfusimotors.com/2018/12/27/how-muscle-age/. Although muscle function declines 
with age, muscle function can vary greatly between  individuals and can be modulated by 
exercise (right) (Sayer et al. 2013). 
1.1.5 C. elegans as model organism for ageing research 
 
The genetics of ageing have proven instrumental in establishing a cause and effect 
relationship between gene function and life span. Short-lived model organisms such 
as C. elegans, Drosophila melanogaster, yeast, and mouse, have contributed 
enormously to our current understanding of the biology of ageing because we can 
see how genes impact longevity. The nematode C. elegans has proven to be 
aparticularly important organism to study ageing, since it provided for example, the 
very first single gene mutants that extend animal longevity (Klass 1977). 
C. elegans is a small soil dwelling nematode established as a genetic model 
organism by Sydney Brenner in 1974 (Brenner 1974). It is only 1mm in length, 
transparent, and comprised of only 959 somatic cells, thus facilitating its cellular 
development to be traced in entirety from embryo to adult (Sulston et al. 1983). 
Moreover its neural connectivity has been determined by EM reconstruction, 
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providing the first connectome of any metazoan (White et al. 1986).  Because of its 
cellular simplicity, fluorescently tagged proteins (e.g. green fluorescent protein) as 
vital cellular fusion proteins were pioneered in the worm by Chalfie (Chalfie et al. 
1994), and are easily visualized in the live animal under the microscope. Protein 
localization and changes of expression over time can be monitored in high cellular 
precision. C. elegans also has facile genetics and its genome is sequenced, enabling 
genetic screens, transgenesis, and genome engineering. The genome of C. elegans 
contains about 22000 genes (Consortium 1998), encoding molecular pathways that 
are highly conserved in evolution. Remarkably, it was first discovered in C. elegans 
by Andy Fire that gene knock down can be achieved by feeding double stranded 
RNA expressing bacteria (RNAi) (Fire et al. 1998). Whole genome RNAi libraries 
(Boutros and Ahringer 2008) as well mutagenesis and genome sequencing have 
been used in unbiased genetic screens for various physiologic processes. Highlights 
include the discovery of the first genes involved in regulating apoptosis (Ellis, 
Jacobson, and Horvitz 1991), the systematic cloning of the genome (Coulson et al. 
1986), the discovery of microRNAs (miRNAs) (R. C. Lee, Feinbaum, and Ambros 
1993) and ageing. Furthermore, C. elegans exhibits visible signs of tissue 
deterioration associated with the process of ageing. These phenotypic changes, as 
pharyngeal sarcopenia, loss of motility, bacterial proliferation and changes of gut 
morphology (Herndon et al. 2002) (Chow et al. 2008) (G. D et al. 2002) (McGee et al. 
2011), can be easily measured in the transparent worm. In addition to naturally 
occurring age-associated changes, many diseases can be modelled in C. elegans. 
Transgenic expression of human Aβ or polyglutamine stretches resembles 
Alzheimer´s or Huntington´s disease, respectively (Link 2001) (Morley et al. 2002) 
(Alexander, Marfil, and Li 2014). These fascinating aspects of C. elegans, together 
with its short lifespan (three weeks) and the fact that it can be grown in large 
numbers, makes it ideally suited for studying ageing. 
 
1.1.6 Age-dependent protein misfolding diseases in humans... 
 
Ageing is a major risk factor for disease. Neurodegenerative diseases like 
Alzheimer ́s (AD) and Huntington ́s disease (HD) are tightly linked to advanced age 
(Niccoli and Partridge 2012). Although progressive diseases of the nervous system, 
such as AD and HD have distinctive pathological symptoms, they share a key 
characteristic: the gradual aggregation and accumulation of misfolded proteins in the 
brain. In the case of HD, a gene mutation in the Huntington gene is causing the 
protein to misfold and aggregate. Also in AD, rare hereditary mutations can cause 
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the disease, which usually manifests much earlier in life than the sporadic cases 
(Fidani et al. 2003). Although the cause of the sporadic cases of AD are difficult to 
determine due to their multifactorial origin, mitochondrial dysfunction and production 
of oxidative stress were identified to be risk factors for the manifestation of disease 
(Zetterberg and Mattsson 2014).  
While young individuals are more protected against the risk factors, the deregulation 
and decline of cellular proteostasis mechanisms in older individuals can no longer 
sustain a healthy proteome. As discussed in the previous chapter, the decline in 
defense mechanism against misfolded proteins, like autophagy, could be one of the 
reasons why the incidence of AD doubles every five years after 65 years of age, so 
that AD affects 30%–50% of all people by the age of 85 years (Isik 2010). As 
mentioned before, AD is an enormous psychological burden for the family of the 
diseased person and a financial burden for the economy. 
It is therefore of crucial importance to understand the disease and find suitable 
interventions to treat or even better, prevent AD. 
Figure 4. Strong increase in dementia in our ageing society. Prospective growth in 
numbers (in millions) of people with dementia in high income and low- and middle-income 
countries between the year 2015 and 2050. Data source: (World Alzheimer Report 2019, 
Alzheimer´s Disease International). 
 
1.1.7 ... and how to model them in C. elegans 
In 1995, Christopher D. Link cloned the human 42-amino acid ß-amyloid peptide 
(derived from human amyloid precursor protein cDNA) to produce muscle-specific 
deposits which were immunoreactive with anti-ß-amyloid polyclonal and monoclonal 
antibodies (Link 1995). Worms showed progressive paralysis and are used 
intensively in the field as a model to study modulation of proteotoxic disease. For 
Huntington´s disease, as well as some other diseases, it was shown that the basis 
for disease pathology was an extension of polyglutamine stretches. Richard I. 
Morimoto investigated the threshold of polyglutamine (polyQ) to cause proteotoxicity 
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in C. elegans by expressing varying numbers of polyQ stretches fused to a yellow-
fluorescent protein (YFP) under different tissue-specific promotors. He observed that 
the number of polyQ stretches greatly influences the onset of aggregate formation. 
While Q82 aggregates already appear in embryos, Q35 foci appear at a much slower 
rate and can only be observed after 4-5 Days. Furthermore, he identified the long-
lived mutant age-1 as genetic modifier of protein aggregation (Morley et al. 2002). In 
the following years, delayed onset of proteotoxic aggregate formation was shown in 
several long-lived worm models and therefore, improved proteostasis was correlated 
with longevity. The intriguing advantage to use C. elegans as a model to study 
proteotoxic diseases is its short lifespan and its easy to manipulate genome. 
Huntington´s as well as Alheimer´s are diseases that are occurring at an advanced 
age when proteostasis mechanisms decline, which in worms only takes a few days. 
Furthermore, the beauty of RNAi feeding to get efficient gene knock-down makes C. 
elegans the perfect model organism to identify novel mediators of the proteostasis 
network. 
Figure 5. Influence of ageing on polyQ aggregation and toxicity. (A) Accumulation of 
aggregates in C. elegans expressing polyQ stretches of various length in the body wall 
muscle. (B left) Motility index as a function of age for the same cohorts of animals described 
in A. (B right) Epifluorescence micrographs of the head of an individual Q35 animal at 4 (C), 
7 (D), and 10 (E) days of age, illustrating age-dependent accumulation of aggregates. 
Arrowheads indicate positions of the same aggregates on different days. In E, the animal is 
rotated slightly relative to its position in D. (adapted from (Morley et al. 2002))  
 
1.2 MicroRNAs 	
1.2.1 MicroRNA Biogenesis and Function 
 
MicroRNAs were first discovered in C. elegans by Victor Ambros and Gary 
Ruvkun. The first described microRNA (miRNA), lin-4 (R. C. Lee, Feinbaum, and 
Ambros 1993), is a 22 base pair RNA that regulates the temporal patterning of seam 
cell lineage programs during larval development, and works by downregulating 
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expression of its target, the lin-14 transcription factor by complementary  binding to 
its 3’UTR . A few years later, the let-7 miRNA family was identified to act, as lin-4, 
upstream of heterochronic genes to control late larval stage development (Reinhart 
et al. 2000).  
Several years later it became apparent that C. elegans microRNAs lin-4 and 
let-7, were conserved in evolution and work by a similar mechanism in other species 
(Lagos-Quintana et al. 2001) (Washietl et al. 2005) (Kanamoto et al. 2006) (Caygill 
and Johnston 2008). Furthermore, the discovery that small non-coding RNAs are 
widespread and essential elements of gene regulation started a novel field of 
research focused on unraveling the functions and impact of the non-coding genome 
(Lagos-Quintana et al. 2001) (Zhou, Hu, and Lai 2010) . 
Protein-coding regions represent less than 2% of the total genome, and relatively 
little is known about the regulatory function of the remaining 98% of the non-
coding genome. Among the non-coding genome, several types of small RNAs in 
eukaryotes have evolved to suppress translation and silence expression. Small 
RNAs can be divided into different subgroups, depending on their biogenesis: 
small interfering RNAs (siRNAs), Piwi-interacting RNAs (piRNAs) and microRNAs 
(miRNAs) (Ghildiyal and Zamore 2009). While siRNAs are derived from double-
stranded (dsRNA), and piRNAs are thought to be derived from single-stranded 
(ssRNA) precursors, miRNAs are encoded in the genome and are transcribed by 
RNA polymerase II (RNA Pol II) (Y. Lee et al. 2004; Ghildiyal and Zamore 
2009).  More than two-thirds of all human miRNAs are encoded in intronic regions of 
protein-coding genes as well as in long noncoding transcripts. However, miRNAs can 
also be encoded in exons or in found in chromosomal regions between two genes 
(intergenic) (Shukla, Singh, and Barik 2011). 
The miRNA precursor transcripts, called pri-miRNAs, are long and typically contain 
5′ and 3′ modifications identical to those present in mRNAs (Graves and Zeng 2012). 
This primary transcript is processed by the RNA enzyme, Drosha, to liberate a 
hairpin structured precursor, the pre-miRNA, of around 60–70 nucleotides (nt) in the 
nucleus. Export to the cytoplasm occurs through exportin-5 where the pre-miRNA is 
subsequently spliced by Dicer to produce a microRNA duplex of 22 basepairs 
(O’Brien et al. 2018). Only one strand associates with the Argonaute protein to 
produce the effector RNA-induced silencing complex (RISC), whereas the other 
strand is discarded. Which strand is chosen to be incorporated strongly depends on 
the relative thermodynamic stability of the two ends of the small RNA duplex (Ui-
Tei et al. 2012). The strand with a relatively unstable terminus at the 5′ side is 
typically selected as the guide strand. Another important determinant seems to be 
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the starting nucleotide of the strand (Khvorova, Reynolds, and Jayasena 2003). 
MiRNAs guide the RISC complex to specifically recognize complementary 
sequences in the 3´UTR of messenger RNA (mRNA) and downregulate gene 
expression by one of the two posttranscriptional mechanisms: (1) translational 
repression and (2) mRNA cleavage (Gu and Kay 2010). The degree of miRNA–
mRNA complementarity is a major determinant of the regulatory mechanism process 
(Wahid et al. 2010). In animals, extensive complementarity, resulting in consequent 
cleavage of the targeted message, occasionally occurs but is much more unusual 
(Filipowicz, Bhattacharyya, and Sonenberg 2008). This makes it difficult to develop 
genome-wide computational tools to predict true mRNA targets without too many 
false predictions (Bartel 2009). One major advance in predicting miRNA targets was 
the discovery that the complementarity of the 2-7th nucleotide (5´to 3´) of the miRNA, 
the so-called seed region, to the respective mRNA substantially improves prediction 
reliability. This also implied that this region was of biological importance for miRNA 
target recognition (Lewis et al. 2003). Although this finding improved bioinformatics 
target-prediction tools immensely, another caveat of identifying miRNA targets is that 
miRNAs regulate a broad diversity of biological processes. As miRNAs more often 
repress translation of mRNA targets, rather than degrade target transcripts, 
proteomic analyses are needed to observe the true effect of miRNA regulation. The 
group of Nikolaus Rajewsky measured genome-wide changes in protein synthesis 
using SILAC and found that miRNAs can fine-tune thousands of gene products 
(Selbach et al. 2008). Rajewsky could confirm the importance of the seed sequence 
in the 3´UTR to identify potential miRNA targets and he could further show that the 
fold-change of the protein changes was dependent on the number of seed 
sequences present in the target 3´UTR. In conclusion, a single miRNA can repress 
the production of hundreds of proteins, but the repression is typically relatively mild 
(Selbach et al. 2008). 
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Figure 6. Schematic overview of miRNA processing. Maturation of miRNAs is initiated by 
the production of the primary miRNA transcript (pri-miRNA) by RNA polymerase II or III and 
cleavage of the pri-miRNA by Drosha–DGCR8 (Pasha) in the nucleus. The precursor hairpin 
structure, the so-called pre-miRNA, is then exported from the nucleus by Exportin-5–Ran-
GTP. In the cytoplasm, the RNase Dicer in complex with the double-stranded RNA-binding 
protein TRBP cleaves the pre-miRNA hairpin to its mature length. Only one strand functions 
as the mature miRNA and is loaded together with Argonaute (Ago2) proteins into the RNA-
induced silencing complex (RISC), where it guides RISC to silence target mRNAs through 
mRNA cleavage, translational repression or deadenylation, whereas the passenger strand 
(black) is degraded. (Winter et al. 2009). 
 
1.2.2 MicroRNAs and Ageing 
 
Interestingly those miRNAs having the largest effect on life span, namely lin-
4, mir-84  mir-241, and mir-71, evidently regulate longevity by downregulating the 
insulin-signaling pathway (Boehm and Slack 2005) (Frost and Olson 2011) . 
Downregulation of the insulin/insulin-like growth factor 1 (IGF-1) signaling pathway is 
well known to promote longevity (C. J. Kenyon 2010) by activating the transcription 
factor daf-16/FOXO. In fact,  several other longevity pathways, including the gonadal 
longevity pathway, mTOR, and intermittent fasting also impinge on daf-16/FOXO 
(Antebi 2007) (Yong et al. 2013) (Daitoku, Sakamaki, and Fukamizu 2011) (Becker et 
al. 2010) (Sengupta, Molkentin, and Yutzey 2009). Several studies in mammalians 
reported other miRNAs as participating in regulation of  the IGF-1 pathway, for 
example mir-1 (Elia et al. 2009). Although mir-1 was not reported so far to have a 
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lifespan phenotype, mir-1 targets IGF-1 itself in human cardiac and skeletal muscle 
in physiological as well as pathological conditions (Elia et al. 2009). Furthermore, the 
mir-1 family member mir-796 is reportedly upregulated with C. elegans ageing 
though longevity phenotypes remain uncharacterized (Kato et al. 2011).  
 
1.2.3 mir-1  
 
C. elegans mir-1 is a highly conserved miRNA (Tani et al. 2013) that shares 
complete homology with the human mir-1 (Grad et al. 2003). Belonging to the class 
of so-called “myomirs”, mir-1 is highly expressed in skeletal and heart-muscle and is 
of importance in muscle development (Xinran Xu 2014) and muscle structural 
organization (Mishima et al. 2009). Together with its family members mir-133 and 
mir-206, mir-1 is one of the most intensively studied myomirs, regulating fundamental 
processes of myogenesis, including myoblast or satellite cell proliferation and 
differentiation (Chen et al 2006). Accordingly, mir-1 falls under the control of 
myogenic transcription factors, such as MEF-2 (Wang et al. 2018). Deregulation of 
mir-1 is associated with many cardiovascular diseases ranging from arrhythmia to 
myocardial infarction and heart failure, and with certain types of cancer (J. Li et al. 
2014). Cardiovascular diseases can be caused by decreased as well as increased 
levels of mir-1, supporting the thesis that a tight regulation of miRNA levels is crucial 
for normal physiological functions. Interestingly, mir-1 is also reported to circulate 
after myocardial infarction, and is currently investigated to serve as biomarker of 
cardiovascular disease (C. Li et al. 2012), although it is still hotly debated whether 
circulating miRNAs are just biomarkers or substantial mediators of cardiovascular 
diseases (Fichtlscherer, Zeiher, and Dimmeler 2011). Identifying physiologically 
relevant circulating miRNAs could open a novel avenue of manipulating levels of 
these circulating molecules to treat disease progression. High circulating levels of 
mir-1 are found not only in diseased states, but also after excessive exercise 
(Siracusa, Koulmann, and Banzet 2018). The proposed mechanism here is that 
passive muscle fiber damage releases mir-1. An unhealthy bout of exercise seems to 
dramatically increase mir-1 levels in the muscle, which drop after 3h to 6h back to 
baseline levels. Interestingly, older men seem to have increased baseline mir-1 
levels in their muscles, which do not respond as rapidly to regulation by stimuli as 
exercise as in younger men (M. J. Drummond et al. 2008). The increased mir-1 
levels in older muscles and the general up regulation of mir-1 after an unhealthy bout 
of exercise, strongly suggest that excess mir-1 levels could have detrimental or 
pathological effects in adult individuals. However, as mir-1 is crucial for heart muscle 
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development and mir-1 knockout mice have severe cardiovascular abnormalities, it 
has proven challenging to decipher the optimal levels of this microRNA under stress, 
or to study the loss-of-function of mir-1 in the ageing process. In contrast, C. elegans, 
mir-1 knock-out worms do not show any developmental defects, making them an 
excellent model to study loss-of-function of mir-1 in the adult organism. 
1.3 Proteostasis 	
An organism’s survival greatly depends on its ability to maintain a balance between 
the production of new and the degradation of old and potentially harmful proteins and 
cellular structures.  
Protein homeostasis, or proteostasis, is therefore a crucial pathway that 
consists of pathways that control protein synthesis, folding, trafficking, aggregation, 
disaggregation, and degradation (Balch et al. 2009). Below I will discuss how these 
processes act in the maintenance of a healthy proteome. 
1.3.1 Protein synthesis 
Protein synthesis comprises the manufacture of polypeptide chains from 
amino acid building blocks on the ribosomes, and is one of the most energy intensive 
processes in the cell. It proceeds through three distinct phases, initiation, elongation 
and termination, which are tightly orchestrated through a plethora of highly 
coordinated factors. While mRNA translation is absolutely essential for survival under 
normal growth conditions and adaptation to stress, it was also shown that a  modest 
decrease in translation rate extends lifespan in several model organisms, including 
yeast, Drosophila and nematodes (C. Kenyon et al. 2007) (Oakes et al. 2008) 
(Syntichaki, Troulinaki, and Tavernarakis 2007) (Katewa et al. 2009). Several 
theories have been proposed to explain these paradoxical findings. Rapid 
biosynthesis is accompanied by the production of non-functional proteins due to 
translational errors or mistakes in protein folding. Accumulation of damaged proteins 
is one of the main factors that causes cellular dysfunction and ageing. Therefore, by 
downregulating global protein biosynthesis, the load of misfolded proteins decreases 
which could lead to less toxic protein aggregates in the cell (Hipkiss 2007). In this 
context, the protein quality control mechanisms play a crucial role, which is known to 
decrease with age (López-Otín et al. 2013). Therefore, a decreased load of newly 
synthesized proteins would allow for improved protein quality control of existing 
proteins. Another possible theory is that protein synthesis is one of the most energy-
consuming processes in the cell. Reduction of translation could therefore increase 
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overall energy availability. These resources could then be used for cellular 
maintenance and repair processes, promoting animal lifespan (C. Kenyon et al. 
2007). Alternately, downregulation of translation can cause proteomic remodeling 
and selective expression of stress factors, which may help cells deal with 
multifactorial stress. Clearly these hypotheses are not mutually exclusive and could 
be at work simultaneously. 
1.3.2 Protein degradation 
 
Rapid protein synthesis can lead to misfolding of nascent proteins or introduce errors 
of translation that destabilize proteins (D. A. Drummond and Wilke 2010). Therefore, 
it is essential to have elaborate mechanisms that can re-fold or eliminate those 
proteins. Re-folding of proteins is assisted by chaperones. One well-studied example 
of ER resident chaperones involved in the correct folding of nascent peptides is the 
highly expressed heat-shock-protein 70 (HSP70) binding immunoglobulin protein 
(BiP/HSP-4) (Gething 1999). However,  BiP is also a stress-induced master regulator 
of the unfolded stress response (UPR), a program designed to relieve ER stress by 
promoting the correct folding of peptides resident in the ER lumen (Y. Ma and 
Hendershot 2004). 
     However, when proteins become toxic aggregates, they need to be eliminated. 
The two major proteolytic pathways that degrade most cellular proteins in eukaryotic 
cells are:  the ubiquitin–proteasome system (UPS) and autophagy.  
 
1.3.2.1 Ubiquitin–proteasome system (UPS) 
 
The UPS catalyzes the majority (around 80%) of protein degradation and is therefore  
absolutely required to assure a healthy proteome and cell survival (Collins and 
Goldberg 2017). To be destined for turnover by this pathway, proteins must be 
modified by polyubiquitin (polyUb) chains at lysine residues (Finley 2009). This 
polyubiquitylation of substrate proteins is mediated by an enzymatic cascade that 
involves the sequential actions of Ub-activating (E1), Ub-conjugating (E2), and Ub-
protein ligase (E3) enzymes (Hershko 1998). The next steps in the degradation 
process involve the 26S proteasome, which consist of a barrel-shaped 20S core 
particle, capped on one or both ends by the 19S regulatory particle (Budenholzer et 
al. 2017) (Richly et al. 2005). The 26S proteasome is transcriptionally induced upon 
stress and its proteolytic activity and substrate specificity is highly regulated by post-
translational modifications (Collins and Goldberg 2017) (Livneh et al. 2016).  
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  In contrast to the former concept of separate proteolytic pathways there is 
growing evidence that there is crosstalk and interplay between UPS and autophagy 
(Korolchuk, Menzies, and Rubinsztein 2010) (Liebl and Hoppe 2016). Although it is 
widely accepted that UPS is the major degradation route for small and short-lived 
proteins (Schreiber and Peter 2014), whereas autophagy degrades mainly large 
proteins as well as aggregates (Ravikumar B., Duden R. 2002), the key regulatory 
factors that target selected substrates to one or the other proteolytic remain largely 
unknown. Ubiquitylation plays a major role in both degradation pathways and it has 
been reported that factors that direct a substrate toward a particular route of 
degradation might include ubiquitin chain length and linkage type (Clague and Urbé 
2010). Interestingly, it has been shown that autophagy can even degrade 
proteasomes in response to starvation (Cuervo et al. 1995). 
 Although there is growing evidence that there is a crosstalk between both 
proteolytic pathways, I will concentrate on autophagy and especially the lysosome in 
the following sections and in my PhD work.  
 
1.3.2.2 Autophagy 
 
Christian de Duve was the first to discover lysosomes around 60 years ago. 
This discovery was, as many ground-breaking discoveries, an accidental but 
astonishing discovery while trying to purify his enzyme of interest. De Duve was 
interested in studying insulin signaling by investigating the in vitro function of hexose 
phosphatase. His enormous efforts of optimizing fractionation methods led him to the 
discovery that 95% of glucose-6-phosphatase was associated with the microsomal 
fraction. This finding led him to the assumption that enzymes have unique subcellular 
locations (Bowers 1998). More astonishing was the observation of another enzyme, 
again a serendipitous event. De Duve observed a low activity of acid phosphatase in 
all fractions he purified and placed it in the fridge for later experiments, only to 
observe a markedly increase in activity of the enzyme a few days later. Within a 
relatively short time, de Duve and his coworkers obtained solid evidence that the 
latency of acid phosphatases was due to a sequestration of the enzyme behind a 
membrane barrier which prevented access of the substrate. De Duve and his 
colleagues named these new particles lysosomes (de Duve et al. 1955). 
        However, autophagy did not get much attention as a cellular process for almost 
30 years. A breakthrough in autophagy research came when Yoshinori Ohsumi 
conducted a laborious genetic screen in yeast to dissect the process (Tsukada 
1993). He identified 15 autophagy-related proteins (ATG), which are essential to 
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protect yeast cell against nitrogen starvation and was awarded, as de Duve, a Nobel 
price.  
In the early years of autophagy research, it was shown that autophagy is inhibited by 
insulin (Pfeifer 1977) and by amino acids (Mortimore, GE, Schworer 1977). These 
findings together with the groundbreaking observation that the drug rapamycin, 
inhibitor of TOR, induces autophagy (Blommaart, E.F., Luiken, J.J., Blommaart, P.J., 
van Woerkom, G.M. & Meijer 1995) confirmed our understanding of autophagy as a 
catabolic, energy-generating mechanism. 
In the past years, intensive research in the field has uncovered the 
importance of autophagy in health and several diseases, including tumors, 
neurodegeneration and cardiomyopathies (Levine, Kroemer, and Roussy 2008). 
Autophagy is a vital process to maintain nutrient availability for the cell under 
stressful situations, like nutrient starvation. Initially, it was assumed that the cell 
would non-selectively 'self-eat' cellular components for survival. Only recently, has it 
become evident that autophagy can also selectively eliminate potentially harmful 
cytosolic materials, like misfolded proteins, and thereby acts as an important 
pathway to maintain proteostasis (Ravikumar et al. 2004) (Komatsu et al. 2007) 
(Levine, Kroemer, and Roussy 2008).  
There are three distinct mechanisms of autophagy: 
Macroautophagy (hereafter referred to as autophagy) is the process in which 
cytosolic components, big aggregates, parts of organelles or whole organelles are 
enclosed by membranes, the so called autophagsosome, and delivered to the 
lysosome for their degradation by lysosomal enzymes. Early studies already 
suggested that the lipid membrane used for autophagosome formation is taken from 
preexisting membranes as autophagosomes can even be formed when protein 
synthesis is almost completely inhibited (Hwang et al. 1974) (Locke and Sykes 
1975). Recently, it has been established that ER, the Golgi apparatus, mitochondria 
and even the plasma membrane can serve as sources for the autophagosomal 
membrane (Locke and Sykes 1975) (Hayashi-Nishino et al. 2009) (Axe et al. 2008) 
(Hailey et al. 2010) (Ravikumar et al. 2010). The understanding of how various 
autophagy substrates are recruited or selectively sequestered by autophagosomes 
has developed rapidly (Stolz, Ernst, and Dikic 2014). Whereas the autophagy 
response to starvation is bulk degradation of cytosolic material, other types of 
stresses can trigger selective autophagy, whose selectivity is achieved trough 
autophagy receptors. These highly conserved receptors recognise on the one hand 
the cargo tagged with degradation signals and on the other hand the 
autophagosomal membrane through their LC3-interacting regions (LIR) (Rawet 
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Slobodkin and Elazar 2013) (Meijer et al. 2007) (Kirkin, Lamark, et al. 2009) 
(Behrends et al. 2010).  
The most prevalent degradation signal in mammals is the modification of cargos with 
Ubiquitin (UB) (Kirkin, McEwan, et al. 2009). In agreement with Ubiquitin being 
important for cargo recognition in autophagy, it has been reported that most of the 
currently known autophagy receptors harbour UB-binding domains (Wild, McEwan, 
and Dikic 2014). Once the autophagosome is sealed, it can fuse with the lysosome to 
enable degradation of its cargo (Liou et al. 1997) (Berg et al. 1998).  
The disintegrated cargo is then shuttled to the cytosol to be available as building 
blocks for nucleic acids, proteins and lipids (Yang, Z., Klionsky 2009).  
The lysosome itself can also directly degrade cellular components. This 
process is called microautophagy and describes the engulfment of cytosolic 
components by invagination of the lysosomal membrane (De Duve 1966) (Kunz, 
Schwarz, and Mayer 2004). Besides macro- and microautophagy, there is also a 
third form of autophagy.    
Chaperone-mediated autophagy (CMA) differs from the other forms of 
autophagy in both the way in which cargo proteins are recognized for lysosomal 
delivery and the way in which these proteins reach the lysosomal lumen. Cytosolic 
chaperones recognize a pentapeptide motif and unfold their substrates. Lysosomal 
chaperones are required to pull the unfolded protein inside the lumen of the 
lysosome, where it is degraded. A critical component for CMA is a receptor in the 
lysosomal membrane, the lysosome-associated membrane protein (LAMP) type 2A, 
to which the protein substrates bind (Majeski and Fred Dice 2004) (Dice 2007) 
(Cuervo and Wong et al. 2011). 
      
 
Figure 7. Schematic overview of the steps of autophagy. Autophagy is initiated by the 
formation of the phagophore (Vesicle nucleation). Expansion of the phagophore (Vesicle 
elongation) is a highly coordinated process which happens at the phagophore assembly 
site (PAS). The forming complex can engulf bulk cytoplasm nonspecifically, including 
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entire organelles, or target cargos specifically. Once the phagophore membrane is closed, 
it is called the autophagosome. When the outer membrane of the autophagosome fuses 
with an endosome (forming an amphisome before fusing with the lysosome) or directly 
with a lysosome (docking and fusion steps), it forms an autophagolysosome. Finally, the 
sequestered material is degraded inside the autophagolyosome (vesicle breakdown and 
degradation) and recycled. (wormbook.org) 
 
1.3.2.3 The lysosome and v-ATPases 
 
 The key to substrate degradation in all three forms of autophagy is the acidic 
environment of the lysosome. The lysosome contains about 50 different degradative 
enzymes, all of them being acid hydrolases, that can hydrolyze proteins, DNA, RNA, 
polysaccharides and lipids (Pu et al. 2016). The acid hydrolases are inactive at a 
neutral pH (about 7.2) which is important to protect against uncontrolled digestion of 
the contents of the cytosol when the lysosomal membrane would break down 
(Alberts et al 2002). To maintain an acidic pH (about pH 5) for proper functioning of 
the acid hydrolases, lysosomes must actively concentrate H+ ions (Huynh and 
Grinstein 2007). This is accomplished by a proton pump called the vacuolar ATPase, 
which hydrolyzes ATP to maintain the hundredfold higher H+ concentration inside the 
lysosome (Mellman, I., Fuchs R. 1986).  
V-ATPases are large multi-subunit complexes, composed of an ATP-
hydrolytic domain (V1) and a proton translocation domain (V0), and operate by a 
rotary mechanism (Nishi and Forgac 2002). Electron microscopy image analysis has 
provided a general outline for the structural organization of the v-ATPase (Muench et 
al. 2009) (Wilkens, Zhang, and Zheng 2005) (Diepholz et al. 2008). The v-ATPase 
consists in total of 14 subunits. V1 is composed of subunits A-H and is responsible for 
ATP hydrolysis. The V0 domain is composed of subunits a, d, e, c, and c´ and carries 
out the proton transport (Cotter et al. 2015).  
However, the v-ATPase is far more than just a proton pump and is involved in 
the regulation of numerous pathways. 
Besides its function in protein degradation, lysosomes are also important for receptor 
recycling and endosomal trafficking (Scott et al 2010) (Huotari J. 2011). It has been 
shown that the acidic pH of the lysosome is important for processing of pro-
hormones, like insulin, gastrin and thyroxine, to their biologically active form (Fisher 
and Scheller 1988). In specialized cells, the v-ATPase can confer certain important 
features of the cells, like maintaining a neutral cytoplasmic pH in neutrophils and 
macrophages (Brisseau et al. 1996) or neurotransmitter release into the synaptic 
space in neurons (Moriyama, Maeda, and Futai 1992).  
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Furthermore, the v-ATPase is more and more considered to serve as important 
metabolic sensor as it is shown that mTOR, which is activated on the lysosomal 
membrane, needs the activity of the v-ATPase for its activation (Zoncu et al. 2011). 
Furthermore, it has been shown that the v-ATPase can sense amino acid availability 
(Zoncu et al. 2011). In addition, the a subunit of V-ATPase also interacts with 1-
phosphofructokinase, an enzyme that catalyzes the rate-limiting step in glycolysis 
(Su et al. 2003) (Su et al. 2008) 
In agreement with its important role in multiple, essential processes, the v-
ATPase is also reported to impact lifespan. Lysosomal pH decreases with age and 
this decrease was directly associated with mitochondrial dysfunction and shortened 
lifespan in yeast (Hughes and Gottschling 2012). Moreover, it was shown that 
lysosomes and mitochondria physically interact with other, possibly to exchange 
lipids and other nutrients (Elbaz-Alon et al. 2014) (Hönscher et al. 2014).  
In C. elegans, one regulatory subunit of the v-ATPase, vha-13,  was described to 
play an important role in germ line rejuvenation (Adam Bohnert and Kenyon 2017). 
Furthermore, the lysosomal acid lipase LIPL-4 is highly expressed under conditions 
associated to extended lifespan in C .elegans (Lapierre et al. 2011), and 
overexpression of LIPL-4 itself is sufficient to extend lifespan via the generation of 
the fatty acid oleoylethanolamide (OEA), which shuttles to the nucleus triggering 
the transcriptional activation of target genes (Folick et al. 2015). 
Due to the importance in regulating multiple essential cellular programs and 
its implication in lifespan regulation, it is of great interest to understand the impact of 
the v-ATPase and lysosomes in the process of ageing.  
 
Figure 8. Schematic overview of V-ATPase complex 
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V-ATPase is a highly conserved complex which consists of a peripheral V1 domain that 
hydrolyzes ATP and an integral Vo domain that translocates protons across the membrane. 
The A and B subunits, which are the core subunits of the V1 domain, form ATP binding and 
hydrolysis pockets. In the Vo domain, the a and e subunits are adjacent to a proteolipid ring, 
which is composed of the c, c′, and c″ subunits. The V1 and Vo domains are connected by a 
central stalk composed of the D, F, and d subunits and surrounded by a peripheral stalk 
composed of the C, E, F, G, and H subunits of the V1 domain. Protons are translocated from 
the cytoplasm to the lumen with a force driven by ATP hydrolysis.  
 
1.3.2.4 Regulation of the autophagic process 
 
Lysosomes are not only the terminal degradation compartments, but are also 
connected to the autophagic process at the signaling level. For example, they 
represent a molecular hub controlling the activity of the mammalian target of 
rapamycin complex 1 (mTORC1) complex, which negatively regulates autophagy. 
Upon nutrient availability, mTORC1 inhibits autophagy by directly phosphorylating 
and thereby suppressing the activity of the autophagy initiator kinase complex (Jiang 
et al. 2009). Interestingly, mTORC1 exerts its function on the lysosomal surface and 
its docking can directly be influenced by the lysosome. Amino acid abundance in the 
lysosomal lumen seem to enable the docking of mTORC1 to the lysosomal surface. 
More precisely, ATP hydrolysis by the v-ATPase was necessary for amino acids to 
regulate the translocation of mTORC1 (Zoncu, Liron Bar-Peled, Alejo Efeyan, Shuyu 
Wang, Yasemin, Sancak 2011). Thus, there seems to be a tight link of regulation 
between regulators of autophagy and the autophagic process itself. Another 
important regulator of autophagy is the transcription factor EB (TFEB), which is 
involved in the expression of lysosomal biogenesis by directly regulating lysosomal 
genes (Di Malta et al. 2011). One major regulator of TFEB is –among others- 
mTORC1, which can phosphorylate TFEB and thereby prevent its nuclear 
translocation (Y. Chen et al. 2012). 
Yet another interesting regulator of autophagy is the Forkhead Transcription 
factor FOXO, especially in muscle cells. Christina Mammucari et al showed that 
FOXO3 regulates autophagy in skeletal muscle atrophy independent of mTOR. 
Overexpression of FOXO3 significantly increased the level of lipidated LC3, which 
was found to be due to direct regulation of LC3 transcript by FOXO (Mammucari et 
al. 2007). Although it was reported that FOXO increases autophagy during muscle 
atrophy and is therefore contributing to muscle wasting in the young (Mammucari et 
al. 2007) (Brault et al. 2007). As myofiber atrophy typically results from decreased 
protein synthesis and increased protein degradation, it was thought that also in 
ageing, increased autophagy would lead to sarcopenia. However, it is well known 
that many age-related diseases arise from accumulation of misfolded proteins and 
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dysfunctional organelles and that autophagy can ameliorate proteostasis in such 
conditions (Douglas and Dillin 2010). The muscle is a metabolically active tissue and 
is challenged with constant oxidative stress, for example during exercise. Therefore, 
it requires a well-functioning proteostasis-network, which declines with ageing 
(López-Otín et al. 2013). Autophagy genes (Micah J. Drummond et al. 2014) as well 
as proteins (Russ et al. 2015) are shown to be decreased in aged muscles, which 
could contribute to the decline in autophagic function. Furthermore, muscle-specific 
deletion of a crucial autophagy gene, Atg7, resulted in profound muscle atrophy and 
an age-dependent decrease in force (Masiero et al. 2009). Thus, autophagy is 
required to maintain muscle mass and FOXO seems to play an important role in 
autophagy regulation.  
 
1.3.2.5 Autophagy and Ageing 
 
Accumulating evidence is revealing autophagy as important regulator of 
organismal lifespan (Rajawat, Hilioti, and Bossis 2009) (Martinez-lopez et al. 2015).   
Decreased macroautophagy with age has been reported extensively in a variety of 
different model organisms (Del Roso et al. 2003) (Rubinsztein, Mariño, and Kroemer 
2011). In 2010, an unbiased large-scale genetic screen for yeast chronological 
ageing factors found that the confirmed short-lived mutants were those defective for 
autophagy, indicating a key requirement for the recycling of cellular organelles in 
longevity (Smith et al. 2010). Also in Drosophila, a mutation in the atg8 gene reduced 
lifespan, whereas overexpression of atg8 in older flies extended their lifespan 
(Simonsen et al. 2008). In C. elegans, loss-of-function mutations in several 
autophagy genes, like atg9, atg-18, bec-1, lgg-1 and unc-5, led to a decrease in 
lifespan. Furthermore, Márton L. Tóth et al showed that autophagy genes are 
required for life-extension in various long-lived mutant strains, implying that the 
effects of mutations affecting distinct longevity pathways converge on common 
downstream processes that involve autophagy (Takács-Vellai et al. 2014). The 
knockdown of autophagy leads not only to shortened lifespan, but also increased 
age-associated pathologies like triglyceride accumulation, mitochondrial dysfunction 
and muscle degeneration (Karin et al. 2010). In mice, knockdown of autophagy 
genes is lethal during the early postnatal period, but tissue-specific knockout of Atg 
genes have a less dramatic phenotype and instead also manifest multiple age-
associated pathologies like neurodegeneration (Murata et al. 2006) or accumulation 
of Amyloid-beta (Aß) in the mouse brain (Pickford et al. 2008). Zhan and Cuervo 
noted that the expression of Lamp2a, a lysosomal protein, is decreased with age and 
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that reinstatement of normal LAMP2a levels averts the aging-associated defect in 
chaperone-mediated autophagy (CMA) and macroautophagy (C. Zhang and Cuervo 
2008). Lysosomal biogenesis and microautophagy could therefore also play a crucial 
role in the ageing process. In line with that, Bohnert and Kenyon reported that a 
lysosomal switch triggered proteostasis renewal in C. elegans germ lineage to 
„rejuvenate“ the oocyte (Adam Bohnert and Kenyon 2017). Sperm stimulates v-
ATPase activity in oocytes which in turn activates lysosomes and promote aggregate 
clearance to reset proteostasis. So far, this was only shown in the immortal germ 
line, but it would be of particular interest to test whether lysosomal proteostasis can 
be induced in the ageing soma to reverse age-related phenotypes. 
The question how autophagy decreases with age remains unclear. Given the 
complexities in the orchestration of autophagy, it is likely that the mechanisms 
contributing to inhibition of autophagy are complex and multifactorial. 
1.4 Link between microRNAs and proteostasis 	
As miRNAs are regulating multiple cellular processes, it is unsurprising that they play 
a part in complex, multifactorial cellular processes such as proteostasis and therefore 
influence human disease and cellular and organismal ageing. MiRNAs are implicated 
to regulate many of the hallmarks of ageing (Harries 2014).  
As miRNAs have hundreds of targets and modulate gene expression by fine-tuning 
mRNA levels, it is challenging to identify their involvement in one particular pathway. 
In this chapter, I want to highlight studies that implicated a direct link between 
miRNAs and the regulation of the proteostasis network.  
One recent study could show that a miRNA, which is only expressed in the nervous 
system, can regulate proteostasis in the intestine of C. elegans. Finger et al. showed 
that mir-71 promotes ubiquitin-dependent protein turnover, particularly in the 
intestine. Interestingly, this process is regulated by olfaction and mir-71 triggers 
this cell-nonautonomous communication from the olfactory neurons to the intestine 
by directly regulating tir-1, a Toll-receptor-domain adaptor protein in AWC neurons 
(Finger et al. 2018). Until now, it was largely unknown whether miRNAs are able to 
respond to metabolic clues and attempt to regulate homeostasis. This work 
contributed largely to the understanding of the relation between metabolism and 
proteostasis and showed that miRNAs can greatly influence the communication 
between both pathways. 
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Furthermore, Zhang et al recently identified miRNAs, especially mir-122, as critical 
mediators of caloric restrichtion (CR) in inducing mitochondrial UPR (UPRmt ) to 
improve mitochondrial proteostasis (Zhang et al. 2019). 
In addition, knockdown of a single miRNA, mir-378, causes muscle atrophy in 
mice. The miRNA was previously established as a critical regulator of hepatic 
insulin signaling during fasting (Liu et al. 2014). The muscle atrophy could be 
explained by the regulation of autophagy by mir-378 (Y. Li et al. 2018). PDK-1, 
being a direct target of mir-387, mediates the effect of the miRNA on autophagy in 
skeletal muscle. These findings again show that miRNAs are powerful regulators 
of cellular and organismal processes, by acting autonomously and non-
autonomously. 
MiRNAs are also being implicated in regulating proteins of the autophagic process 
directly (Jing et al. 2015). This direct regulation of autophagic components could 
potentially be interesting for treatment of cancer. Treatment of tumor cells with the 
miR-30a mimic decreased, and with the antagomir increased, the expression 
of beclin-1 mRNA and protein (Yang et al. 2014). Also mir-1 was recently shown to 
regulate the autophagic process in a drug resistant non-small cell lung cancer 
(NSCLS) cell line (Hua, Zhu, and Wei 2018). Overexpression of mir-1 reduced GFP-
LC3 positive cell percentage by directly inhibiting ATG3. There is still debate in the 
field whether induction or inhibition of autophagy is beneficial in cancer treatment, but 
miRNAs, as druggable targets, could play an important role in this regulation.  
Although, intensive effort is made, the interaction between autophagy and miRNA is 
extremely complex and still poorly understood.  
1.5 Role of non-autonomous regulation of proteostasis 	
All biological systems are constantly exposed to a diversity of physiological and 
environmental stimuli, ranging from acute to chronic, leading to an accumulation of 
age-associated damage and dysfunction. Horvath postulated that tissues age at 
different rates (Horvath 2013). He based his finding on methylation profile as 
indication of ageing status of the different tissues. This finding raises the question 
whether tissue ageing is an isolated, autonomous process or if tissues 
communicate with each other to inform neighboring or distant tissues about their 
state of ageing. In C. elegans, reducing insulin/IGF-1-receptor DAF-2 doubles the 
lifespan of the animals. Throughout their lives, they closely resemble younger wild-
type animals. Thus, the ageing in all tissues seem to happen normally, just at a 
slower pace, suggesting an equal cell-autonomous reduction of insulin/IGF-1 
 33 
action in all tissues. Surprisingly, a genetic mosaic analysis indicates that signaling 
between different tissues plays an important role in daf-2 longevity (Apfeld and 
Kenyon 1998). Apfeld and Kenyon removed daf-2 from early blastomeres, so that 
only some tissues have reduced daf-2 expression. Although they observed some 
variability in the phenotype they could show that mosaic animals went into Dauer 
and lived longer than wild-type controls. Their results indicate that cells that lack 
daf-2 activity not only change their own rates of ageing, but also signal to wild-type 
cells to change their rates of ageing. In a later study, Coleen T. Murphy, Seung-
Jae Lee, and Cynthia Kenyon could establish the intestine, which is the animals 
entire endoderm, as an important non-autonomous insulin-signaling center (Murphy, 
Lee, and Kenyon 2007).  
The proteostasis network serves in all cells to maintain proteostasis and prevent 
protein misfolding in the face of development and aging. Small heat-shock proteins 
that help refolding misfolded proteins are a crucial facet in the maintenance of 
cellular proteostasis (Morimoto 2008). Even though the proteomes expressed for 
example in muscle or neuronal cells are highly distinct according to their specialized 
function, the highly conserved cellular stress responses are functioning in all tissues 
(Balch et al. 2009). It might seem counterintuitive to communicate the protein folding 
defects that occur in a single tissue to elicit the same stress response in other non-
affected tissues or even throughout the entire organism. Therefore, proteostasis 
regulation had been considered to be a cell-autonomous process. However, in a 
multicellular organism, intercellular communication to ensure that tissue-level 
proteostasis is balanced across the organism throughout development, acute and 
chronic stimuli and the ageing process seems useful.  
 
1.5.1 Neuronal control of organismal proteostasis 
 
An important organ to coordinate stress responses in the organism is the brain. As 
for many groundbreaking discoveries, C. elegans was the model organism in which 
Prahlad et al showed in 2008 that the AFD neuron is required to induce heat-shock-
factor-1 (HSF-1)-dependent heat-shock protein 70 (hsp70) induction in multiple 
tissues (Prahlad, Cornelius, and Morimoto 2008). This study demonstrated that the 
organismal heat-shock response can be regulated in a non-autonomous manner. 
Prahlad used a temperature-stress and found that gcy-8, a guanylyl cyclase that is 
solely expressed in the two AFD neurons, is necessary for the induction of the stress 
responses in other tissues. But what about a stress that only one single tissue 
experiences? Jenni Durieux et al. used tissue-specific knock-down of cco-1, an 
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essential component of the electron transport chain (ETC), to induce mitochondrial 
dysfunction in a tissue-specific manner. Strikingly, they found that this perturbation is 
received and acted on in other tissues than that tissue experiencing the stress 
(Durieux, Wolff, and Dillin 2011). Furthermore, they could show that reducing 
mitochondrial ETC in only one tissue can confer longevity, probably trough the 
regulation of global stress responses. Especially the neuronal control, to 
communicate the stress, seems to be important. After further investigations of the 
non-autonomous stress regulation pathway, Rebecca C. Taylor and Andrew Dillin 
reported XBP-1 as cell non-autonomous regulator of stress resistance and longevity 
(Taylor and Dillin 2013). Global stress responses like the endoplasmic reticulum 
unfolded protein response (UPRER) are not only declining with the aging process, 
their induction is also less efficient in aged worms. This age-related loss of ER 
proteostasis could be reversed by expressing constitutively active XBP-1 s, thereby 
prolonging lifespan. Interestingly, expressing the constitutively active form of XBP-1s 
solely in the neurons, was sufficient to rescue the age-related loss of proteostasis in 
distal tissues and confer longevity. Furthermore, they could show that small 
neurosecretory vesicles confer the systemic effect as unc-13 mutants failed to 
communicate the neuron-specific XBP-1s stress response to distal tissues. This 
finding suggests that neurotransmitter could act as messenger molecules in this non-
autonomous signaling pathway.  
 
1.5.2 Non- neuronal tissues as non-autonomous regulators 
 
Neurons provide rapid systemic communication across tissues as they sense and 
transmit physiological and environmental signals to coordinate and integrate cellular 
and tissue responses. Interestingly, observations in C. elegans revealed that also 
nonneuronal communication is essential for organismal proteostasis and stress 
responses. The imbalance of proteostasis through the expression of a metastable 
myosin increases heat-shock protein 90 (HSP90) not only in muscle cells but also in 
different cell-types, such as the intestine (Van Oosten-Hawle, Porter, and Morimoto 
2013). Also neuronal HSP90 expression was regulated through muscular 
proteostatic stress, indicating that neurons respond to signals coming from peripheral 
tissues. In D. melanogaster it was further demonstrated that dFOXO regulates 
ageing when activated only in pericerebral fat body and that this fat-specific increase 
in dFOXO decreased insulin signaling in the brain as measured by RT-PCR of dilp-2 
(insulin-like-peptide) (Hwangbo et al. 2004). Among all age-related pathological 
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conditions, the gradual decay in muscle strength is one of the first hallmarks of 
ageing in many organisms, including Drosophila, C. elegans, mice and humans. 
FOXO regulates the expression of a series of target genes involved in stress 
responses and has been reported to prevent the pathogenesis of some age-related 
diseases. For example, FOXO reduces the toxicity associated with aggregation-
prone human mutant Alzheimer´s and Huntington´s disease proteins in C. elegans 
(Hsu, Murphy, and Kenyon 2003) (Cohen et al. 2006). In 2010, Demontis and 
Perrimon showed that FOXO/4E-BP signaling regulates proteostasis via an 
autophagy/lysosome system in the muscle of Drosophila. This prevention of muscle 
ageing by FOXO and 4E-BP was sufficient to extend lifespan. Furthermore, they 
demonstrated that muscle-specific FOXO/4E-BP signaling regulates proteostasis in 
other ageing tissues (Demontis and Perrimon 2010). This non-autonomous effect 
was due to a decreased feeding behavior of the flies and can therefore be attributed 
to dietary restriction rather than a direct effect of FOXO signaling to other tissues. 
This study supports again the common belief that preserving muscle function is 
beneficial for overall ageing and that the muscle can serve as central tissue to 
coordinate organism-wide processes in a non-autonomous manner. For this 
particular study, as well as many others, it is difficult to find the mediator that 
communicates the non-autonomous signal to other cells or tissues. Two distinct 
scenarios could be conceivable:  
 
1. direct communication: The responsible molecule of the „sender“ tissue 
itself is directly being transported to the „receiver“ tissue to induce the 
same response 
2. indirect communication: The „sender“ releases a distinct messenger 
molecule that can communicate the state of the „sender“ and is able to 
evoke a response in the „receiver“ tissue. 
 
 
Figure 9. Schematic overview of possible mechanism for tissue non-autonomous 
signaling. 1. Direct signaling though a direct release of mir-1 by the muscle to the 
 36 
“receiver” tissue. 2. Indirect signaling through activation of mechanism in the muscle by 
mir-1, which passively evoke a response in the “receiver tissue”.  
 
1.5.3 MiRNAs as non-autonomous regulators 
 
Secreted miRNAs represent a newly discovered mechanism by which donor cells 
can influence the gene expression of recipient cells. Before, it was assumed that 
extracellular miRNAs originate from cell lysis or are released in vesicles as „waste 
products“ of the cells. However, evidence suggests that miRNA packaging occurs 
non-randomly and that specific miRNAs are preferentially sorted into microvesicles 
(Y. Zhang et al. 2010) (Mittelbrunn et al. 2011). Neutral sphingomyelinase 2 
(nSMase2) was reported to regulate the secretion of exosomal miRNAs, suggesting 
exosomes as essential transport vehicle for miRNAs (Kosaka et al. 2010).  The 
nomenclature of small subcellular vesicles is still controversial; however, exosomes 
can be classified as small secreted vesicles with a diameter between 30 and 100 nm, 
containing a variable spectrum of molecules, including RNA, proteins and lipids. As it 
was shown that the endosomal sorting complex required for transport (ESCRT) 
system was not necessary for the release of miRNAs (Kosaka et al. 2010), it is still 
not fully understood how miRNAs are recognized and sorted into excretory vesicles. 
However, evidence has been provided that the loading of miRNAs into exosomes 
might be controlled by specific proteins of the RNA-induced silencing complex 
(RISC). This evidence comes from studies that showed GW182 and Ago2, which are 
parts of the RISC complex, to be enriched in exosomes (Gibbings et al. 2009) (Y. 
Zhang et al. 2010). One other poorly understood issue is how secreted miRNAs are 
taken up into recipient cells and whether specific cells can be targeted for uptake. 
Microvesicle-enclosed secreted miRNAs are postulated to be taken up when they are 
internalized by endocytosis, phagocytosis or direct fusion with the plasma 
membrane. Whether there are also cell recognition molecules on the surface of 
microvesicles that could allow for specificity in uptake is still under investigation and 
could provide interesting possibilities for therapeutic approaches (X. Chen et al. 
2012). It has also been demonstrated that high-density lipoproteins (HDL) can serve 
as transport vehicle for miRNAs and can deliver endogenous miRNAs to recipient 
cells (Vickers et al. 2011). MiRNAs were once thought to be unstable molecules, but 
were recently demonstrated to circulate in a highly stable, cell-free form in body fluids 
(Mitchell et al. 2008). As there is accumulating evidence of a targeted release of 
miRNAs, the burning question whether these miRNAs are entering and controlling 
gene expression in recipient cells is debated.  
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1.5.4 Can secreted miRNAs affect gene expression in recipient cells? 
 
Kickers et al tested whether HDL has the capacity to deliver small RNAs to recipient 
cells. They incorporated HDL with exogenous miRNAs and induced those to cultured 
hepatocytes. In cells treated with HDL-mir-375 complexes, not only the intracellular 
levels of mir-375 increased, but also target mRNA of mir-375 was decreased 
(Vickers et al. 2011). This finding provides evidence that miRNAs enter and also 
influence gene expression of recipient cells. Evidence for non-autonomous gene 
regulation by miRNA is not only coming from in vitro studies but there are also a 
limited number of in vivo studies. The group of Jing Ai observed that cardiac 
overexpression of mir-1 caused cognitive impairment in mice (J. C. Ma et al. 2015). 
 Although mir-1 was expressed under a muscle-specific promotor, mir-1 levels were 
significantly increased in the hippocampus of the mice. RT-PCR analysis revealed 
that pri-mir-1 and pre-mir-1, the precursor forms of mir-1, were not elevated in the 
hippocampus. This suggests that the increased mir-1 levels in the hippocampus are 
due to an uptake of the mature form of mir-1. Blood mir-1 levels were also increased, 
further indicating that mir-1 was secreted. Furthermore, it was shown that brain-
derived neurotrophic factor (BDNF), a direct target of mir-1, was down regulated in 
the hippocampus of the mir-1 transgenic mice. This down regulation could be 
reversed by silencing mir-1 using anti-miR-1 oligonucleotide fragments, carried by a 
lentivirus vector that was injected directly into the hippocampus. The same group 
recently published a follow-up paper, showing that GW4869, an exosome inhibitor, 
was able to block the elevated levels in the hippocampus of the mir-1 Tg mice (Duan 
et al. 2018). Interestingly, this finding could even be conferred to humans as it was 
shown that mir-206, belonging to the mir-1 family, was up regulated in the brain of 
AD patients and suppressed the expression of BDNF (Moon et al. 2016) (Soon-Tae 
et al. 2012). Mir-206 expression was also increased in the group of mild cognitive 
impaired patients and further increased with AD disease progression. The group of 
Kon Chu showed that mir-206 was also elevated in olfactory mucosal cells of AD 
patients, which can be easily isolated and can be utilized as an excellent biomarker 
for the diagnosis of early AD (Moon et al. 2016). Biomarkers for diseases are 
urgently needed in the clinics and circulating miRNAs are very interesting candidates 
in this field of research. Exosomes isolated from the CSF of Alzheimer´s and 
Parkinson´s disease patients identified a variety of deregulated miRNAs compared to 
healthy age-matched controls. Mir-1 was among the most down regulated miRNAs in 
exosomes isolated from disease patients (Gui et al. 2015) and correlated with a 
strong ´degenerative´ pathology. In a different context, mir-1 was suggested as a 
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promising biomarker for measuring exercise intensity. Circulating levels of the mir-1 
family, mir-1, mir-133a, and mir-206 are increased after a half-marathon race or 
marathon race (Gomes et al. 2014) (Clauss et al. 2016), as well as after resistance 
training (Cui et al. 2017). Plasma mir-133a level correlated with increased cortisol 
levels, suggesting mir-133a as a potentially useful biomarker indicating stressful 
training (Cui et al. 2017).  
Taken together, accumulating evidence suggests mir-1 could not only 
serve as promising biomarker for AD progression or stressful exercise, but there 
might also be a link between elevated mir-1 level and pathologies in humans. 
Although mir-1 is absolutely essential for early muscle development, it becomes 
more and more evident that increased mir-1 levels later in life might be associated 
with muscle malfunctioning. Muscle tissue makes up about 40% of body mass and 
due to its high metabolic activity, it is extremely important to maintain cell 
maintenance pathways like proteostasis throughout the ageing process. However, 
as proteostasis declines with age, muscle tissue accumulates misfolded proteins 
which causes a gradual decline of muscle function and sarcopenia. Furthermore, 
despite intensive research, secretory mechanism as well as the biological pathways 
regulated by circulating miRNAs in non-autonomous regulation is still mainly 
unclear. Mir-1 is found in the circulation, especially in pathologic disease background 
and could have a potential role in clinical applications. In summary, it is of crucial 
importance to understand the underlying mechanism of muscle ageing, especially 
muscle specific decline of repair mechanisms and the potential impact of myomirs 
like mir-1, as they could serve as therapeutic targets. Furthermore, non-autonomous 
regulation and action of miRNAs in disease pathologies is greatly unknown and mir-
1, being specifically expressed in the muscle, could be an interesting candidate to 
investigate potential non-autonomous effects of miRNAs as circulating levels of mir-1 
are already described.  
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1.6 Aims of this study 	
Healthy, functional skeletal and heart muscle throughout the life is important to 
maintain physical activity which is crucially important for overall health. Correlation 
studies suggest a potential detrimental effect for elevated mir-1 level in aged 
mammals. Furthermore, mir-1 was found in the circulation and elevated mir-1 levels 
were associated with other pathologies like AD, suggesting a potential cell non-
autonomous regulation by mir-1. As knock-out of mir-1 in higher organism is 
embryonically lethal, it is difficult to address the effect of mir-1 in aged animals. 
Interestingly, mir-1 C. elegans mutants are viable and do not show any 
developmental abnormalities. Furthermore, levels of mir-1 family members increase 
in aged worms (Lucanic et al. 2013) (Kato et al. 2011), and components of the 
proteostasis network (v-ATPases) are predicted by bioinformatical methods to be 
potentially regulated by the mir-1 family in C. elegans (Kato et al. 2011). However, no 
studies investigated the link between mir-1 and proteostasis so far. 
Taken together, studying the effect of mir-1 deletion on ageing in general and on 
muscle proteostasis in particular, could uncover a novel player in muscle ageing 
which could serve as interesting target for drug development. 
 
Aim 1: Does mir-1 affect lifespan and muscle proteostasis? 
 
Aim 2: What are the downstream mediators of mir-1, responsible for improvement of 
protein quality control (PQC)? 
 
Aim 3: Does mir-1 act non-autonomously? 
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2 Results 
 
Ageing is the cause of progressive decline in all organ systems throughout 
the body. This is particularly evident in the musculature and often manifests as 
sarcopenia, the loss of muscle mass and strength. In fact, muscle frailty is a hallmark 
of tissue ageing seen in species as diverse as worms, flies, mice and humans 
(Herndon et al. 2002) (Miller et al. 2008) (Martinez et al. 2007) (Demontis et al. 2013) 
(Cruz-Jentoft et al. 2010) (Nair 2005). At the molecular level, frailty is often 
accompanied by a decline in muscle structure and function, as well as alterations in 
muscle proteostasis and metabolism. Nevertheless, muscle can often respond 
positively to exercise and stress and rejuvenate even into older age, showing 
remarkable plasticity (Pollock et al. 2018) (Cartee et al. 2016) (Distefano and 
Goodpaster 2018). Thus, a molecular study of muscle ageing and plasticity in a 
genetically tractable model could shed light on fundamental aspects of tissue ageing 
and regeneration.  
microRNAs are small 22-26 nucleotide RNAs that bind with complementarity 
through their seed sequence to target mRNAs to downregulate gene expression (Gu 
and Kay 2010). They can work as molecular switches or fine tune gene regulation 
through feedback, and typically have multiple targets, thereby coordinating cellular 
programs. Many microRNAs are expressed in a tissue specific manner and regulate 
programs intrinsically, and could therefore potential serve as tissue specific 
therapeutic targets (Guo et al. 2014) (Panwar, Omenn, and Guan 2017). In addition, 
some microRNAs are also secreted and found in serum, and other body fluids 
(Weber et al. 2010) (X. Chen et al. 2008) , raising the possibility that they can act 
extrinsically as well. 
Mir-1 is a muscle enriched microRNA highly conserved in evolution and is 
essential to mammalian muscle and heart function. Mir-1 mouse knockouts, 
however, are lethal and therefore difficult to study (Zhao et al. 2007). By contrast, C. 
elegans mir-1 deletion mutants are viable, and exhibit modest changes in the 
behavior of the neuromuscular junction. Like its homologs, mir-1 is expressed in 
body wall (skeletal) and pharyngeal (cardiac) muscle (Simon et al. 2008). 
Furthermore, the mir-1 family member mir-796 is reportedly upregulated with C. 
elegans ageing though longevity phenotypes remain uncharacterized (Kato et al. 
2011).  
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In this work I focused on the potential role of the mir-1 in regulating muscle 
function, proteostasis and organismal ageing. I found that mir-1 null mutations result 
in increased motility and reduced aggregate formation under proteotoxic challenge 
during ageing, and show enhanced autophagy and lysosomal function. These 
studies reveal that muscle expressed mir-1 impacts organismal function, and imply 
both cell autonomous and non-autonomous control. 
 
2.1 mir-1 mutants have improved muscle PQC 
 
To unravel mir-1 physiologic functions, I first characterized the nature of mir-1 
mutations. gk276 is the canonical allele and consists of a large 192 base pair 
deletion that removes the mir-1 coding region as well as part of the downstream 
region which does not contain any coding sequence. I also created two independent 
mir-1 alleles by CRISPR genome engineering (Figure 10a):  dh1111 yielded a 52 
base pair deletion within the mir-1 locus, while dh1110 yielded a 267 base pair 
deletion. All three alleles failed to express the coding miRNA, and are thus mir-1 null 
mutants (Figure 10b). I predominately used gk276 and dh1111 for further analysis. 
 To investigate whether mir-1 impacts ageing, I performed demography 
experiments at various temperatures with mir-1 mutants. At 20°C, mir-1 mutants 
developed normally and exhibited no effect on lifespan (Figure 10c). They also 
showed nearly normal brood size and pumping rate (Figure 10d+e). Surprisingly, at 
25°C, however, mir-1 mutants showed a moderate extension of lifespan (Figure 10f). 
In particular, the median lifespan of dh1111 was significantly extended (cf. 15 versus 
17 days), but the maximum lifespan was unchanged, suggesting an effect on 
healthspan. In support of this idea, mir-1 mutants adopted a more youthful posture 
and remained mobile at Day 20 of adulthood compared to wild-type controls (Figure 
10g). Interestingly, mir-1 mutants were more resistant to heat shock at 35°C (Figure 
1h) but were not more resistant to oxidative challenge (Figure 10i). 
For C. elegans, the temperature of 25°C represents a condition of moderate 
thermal stress, which can induce protein misfolding and modest heat shock response 
(Gomez-Orte et al. 2018). Preliminary data suggested that mir-1 mutants showed 
elevated expression of ER UPR heat shock protein hsp-4 and mitochondrial UPR 
hsp-6 compared to wild type under basal conditions (Figure 10j+k).  
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Figure 10. mir-1 mutants develop normally and are more heat stress resistant and 
modestly long-lived at 25°C compared to wild-type. 
(A) Schematic showing mir-1 locus and the three mir-1 deletion alleles. mir-1(gk276), 
obtained from the million mutant project, is mainly used for this thesis. mir-1 (dh1111) and 
mir-1 (dh1110) CRISPR deletion allele is made using the sgRNA Guide described in Material 
and Methods. (B) TaqMan qPCR measuring mature mir-1 levels confirm that all alleles are 
null, N=2. (C) Lifespan analysis performed at 20°C for two independent mir-1 mutant alleles 
compared to wild-type. 75 worms/strain, N=3, Log-rank Test, ns. (D) Brood size measurement 
of mir-1 (gk276) and mir-1 (dh1111) compared to wild-type, N=1. (E) Pharyngeal pumping 
rate measured on day 1, day 4 and day 8 in two mir-1 alleles compared to wild-type, N=1. (F) 
Lifespan analysis performed at 25°C of two mir-1 mutant alleles compared to wild-type. 75 
worms/strain, N=3, Log-rank Test, *, p<0.05. (G) Representative picture of worm posture of 
N2 and mir-1 (dh1111) mutant on Day 20 of adulthood (right). (H) Heat stress resistance 
measured by exposing mir-1 mutants and wild-type worms to 35°C for 8h, N=1, Log-rank, 
****, p<0.0001. (I) Oxidative stress resistance measured by exposing worms to 10mM H2O2 
for 5h, N=1, ns. (J) Images of the ER stress reporter hsp-4p::hsp-4::GFP in mir-1 and wild-
type Day 1 adults under basal and induced (4h 10uM Tunicamycin (TM)) condition, N=1. (K) 
Images of the mito-UPR stress reporter hsp-6p::hsp-6::GFP in mir-1 and wild-type Day 1 
adults under basal and induced (egg-on cco-1 RNAi) condition.  
 
I therefore surmised that the enhanced health of mir-1 mutants at 25°C might 
reflect differences in protein folding or quality control (PQC). To assess the ability of 
mir-1 to withstand proteotoxic challenge, I used strains expressing various lengths of 
polyglutamine tracts fused to yellow fluorescent protein (YFP) under the control of 
the muscle myosin specific unc-54 promoter, which have been used previously as 
models of proteotoxicity and Huntingtin’s disease (Morley et al. 2002) (Brignull et al 
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2006). In these strains, initially soluble proteins become sequestered into insoluble 
aggregates, visible as foci in the muscle of the worm, with longer polyQ stretches 
developing more aggressive aggregation. Indeed, I observed that wild type worms 
harboring polyQ40 stretches already expressed the maximum number of aggregates 
by the L4 stage. Interestingly, mir-1 deletion strongly reduced the amount of 
aggregates formed (Figure 11a+b). Worms expressing the milder polyQ35 stretches 
showed a more progressive age-dependent protein aggregation, which typically 
appeared by Day 4 of adulthood. In this case, too, mir-1 mutants displayed 
significantly less aggregates (ca. 32) compared to age-matched wild-type controls 
(ca 42) (Figure 11c+d). Furthermore, mir-1 mutants not only decreased aggregate 
number, but also improved the solubility of polyglutamine (Figure 11e). The effect of 
proteotoxicity was further investigated by measuring organismal motility, counting 
body bends in liquid culture on day 8 of adulthood. Though the degree of paralysis 
was quite variable between replicates, mir-1 mutants were significantly more mobile 
in all replicates compared to age-matched wild-type controls (Figure 11f+g). Allele 
dh1111 showed the same, albeit slightly weaker phenotype on Q35 motility as the 
canonical gk276 deletion (Figure 11h). The decrease in muscle aggregates was not 
due to a general decrease in transgene expression as the total amount of 
polyglutamine::YFP protein was similar in wild-type worms and mir-1 mutants, as 
measured by Western blot (Figure 11i).The effect was specific for the muscle, as mir-
1 mutants did not show improvements in motility when polyglutamine stretches were 
expressed under a neuronal- promotor (Figure 11j). Importantly, both the decreased 
aggregates and the increased motility could be rescued by re-introducing a wild type 
mir-1 transgene (Figure 11c,d+g).  The similarity of behavior among the different 
alleles and the rescue of these phenotypes by the wild type transgene demonstrate 
that mir-1 is causal for removing muscle aggregates and improving mid-life motility. 
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Figure 11: mir-1 mutants have improved muscle PQC 
(A) Representative images of wild-type and mir-1 mutant animals expressing unc-
54P::Q40::YFP at day 1 of adulthood. (B) Quantification of Q40::YFP aggregates using Image 
J (like in A.), each dot represents one animal, >10 worms per condition, line and error bar 
indicate mean ± SD of one representative experiment, N=3, t-test, ****, p<0.0001. (C) 
Representative images of wild-type and mir-1 mutant animals expressing unc-54P::Q35::YFP 
in the presence or absence of mir-1P::mir-1 at Day 4 of adulthood. (D) Quantification of 
Q35::YFP aggregates using Image J (like in C.), each dot represents one animal, >15 worms 
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per condition, line and error bar indicate mean ± SD of one representative experiment, N=3, 
1way ANOVA, Tukey´s multiple comparisons test, **, p<0.01, ***, p<0.001.  
(E) Representative Western blot of SDS-soluble and SDS-insoluble Q40::YFP fractions of day 
1 adult unc-54P::Q40::YFP  animals in mir-1 mutant and wild-type background, N=1. 
(F) Representative pictures of wild-type and mir-1 mutants worms expressing Q35::YFP at 
day8 of adulthood. Arrowheads indicating position of the worms. Wild-type worms failed to 
reach bacterial lawn due to paralysis. (G) Motility of wild-type and mir-1(gk276) mutant 
animals expressing unc-54P::Q35::YFP in presence or absence of mir-1 OE at day 8 of 
adulthood, measured by swimming assay. 15 worms per condition, each dot represents one 
animal, line and error bars indicate mean ± SD of one representative experiment, N=3, 1way 
ANOVA, Tukey´s multiple comparisons test, *, p<0.05. (H) Motility of two independent mir-1 
alleles (gk276) and (dh1111) and wild-type animals expressing unc-54P::Q35::YFP, 
measured by swimming assay. 15 worms per condition, each dot represents one animal, line 
and error bars indicate mean ± SD of one representative experiment, N=3, 1way ANOVA, 
Tukey´s multiple comparisons test, **, p<0.01. (I) Representative Western blot of total 
Q35::YFP in day 1 adults, N=2. (J) Motility as measured by swimming assay of wild-type and 
mir-1 mutant worms expressing Q86::YFP under a pan-neuronal promotor, N=1.  
 
I next sought to investigate whether mir-1 exerts a general effect on 
proteotoxicity or if it might be specific to the polyQ model. To do so, I examined the 
effect of mir-1 on a model of amyloid toxicity, the human A-beta peptide 1-42 
minigene, which is expressed in the muscle of the worm and gives rise to 
progressive paralysis during adulthood (Link 1995).  mir-1 mutants also rescued the 
gradual decline in motility caused in this model, suggesting a general improvement in 
muscle proteostasis (Figure 12a,b).   
Figure 12. mir-1 deletion also protects against A-beta toxicity.  
(A) Representative pictures of paralyzed vs rolling phenotype in wild-type and mir-1 mutant 
worms expressing unc-54P::human A-beta peptide 1-42 minigene at day 8 of adulthood. 
Arrowheads indicating worms which were able to roll at day 8. 
(B) Quantification of motility (like in A.) measured by percentage mobile worms, >15 worms 
per genotype, N=3, shown mean +SEM, t-test, **, p<0.01. 
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2.2 Informatic screen for downstream mediators of mir-1 induced 
PQC improvement 
 
To identify downstream mediators of mir-1 PQC improvement, I looked for 
potential mir-1 regulatory targets. I first took an informatic approach, and used 
publicly available prediction tools to select potential genes harboring mir-1 seed 
binding sites in their 3’UTR, namely microRNA.org, TargetScanWorm, and PicTar 
(Betel et al. 2008) (Calvin et al. 2011) (Krek et al. 2005). These different prediction 
tools use distinct algorithms that yield different sets of candidates and these lists are 
usually quite extensive. Therefore, I restricted my candidates based on the 
prerequisite that the target was predicted by all three target prediction tools. This 
yielded 60 candidates, 50 of which had available RNAi clones.  
To carry out the primary screen, I looked for clones that abrogated the 
improved motility of mir-1;Q35 worms. Specifically, synchronized L4 larvae were 
transferred to RNAi FUDR plates and transferred twice to fresh plates until day 8 
when motility was scored using the circle test (Figure 13a). This test measures the 
ability of strains to migrate out of a circle within a limited amount of time. String 
analysis of all predicted targets showed a strong enrichment for v-ATPase subunits 
(Figure 13b). Top candidates were selected based on the criteria to fully suppress 
the motility phenotype and were then validated in a secondary screen using the more 
laborious body bend motility assay (Figure 13c). Confirmed candidates (Figure 13d) 
were then counter-screened in wild-type worms expressing Q35 to investigate 
whether the RNAi clones caused general loss of motility in WT or whether they 
specifically reduced mir-1 motility (Figure 13e). Some candidates completely 
abolished mir-1 motility but barely reduced wild-type motility. Strikingly, among them I 
obtained vacuolar-ATPase subunits, as well as the stress response transcription 
factor daf-16/FOXO, a known transcriptional regulator of many v-ATPase subunits 
(Baxi et al. 2017). These candidates contained one conserved mir-1 binding site. 
One caveat of this approach, however, was that wild-type and mir-1 motility assays 
had to be scored on different days (wildtype: day 5, mir-1: day8) as wild-type worms 
were already paralyzed at a timepoint where mir-1 motility was still too strong to 
observe an RNAi phenotype. Therefore, to obtain a more comparable result, I scored 
motility on the day of adulthood where the same percentage of immobile worms was 
observed between the genotypes on luciferase control RNAi (i.e., wild-type = Day 5; 
mir-1 = Day 8.  
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To measure the impact of candidates on proteostasis, I measured the effect 
of their cognate RNAi on Q35 aggregation. In pilot experiments using vha-13 and 
daf-16 RNAi, however, I failed to observe changes in the aggregate phenotype of 
mir-1, when animals were fed RNAi from L4 onwards. (Figure 13f), while earlier vha-
13 RNAi exposure (egg on) led to lethality. Conceivably, the L4 exposure to RNAi 
was insufficient to affect Day 3 adult aggregate formation. In line with this hypothesis, 
I observed that mir-1;daf-16 double mutants suppressed the aggregate phenotype of 
mir-1 single mutants (Figure 13g). Because vha-13 mutants are embryonic lethal, I 
was unable to assess its impact on aggregate formation. Therefore, I focused on the 
motility phenotype.  
 49 
 
Figure 13. RNAi screen for predicted mir-1 targets identifies daf-16 and vha-13 as 
strong candidates for mir-1 mediated regulation of polyQ toxicity.  
(A) RNAi screen workflow with a total of 50 RNAi clones, readout motility was tested using 
the circle test on day 8 of adulthood. (B) String analysis of predicted targets shows strong 
clustering of v-ATPase subunits (C) Validation of candidates of initial screen by swimming 
assay at day 8 of adulthood, 15 worms per condition, each dot represents one animal, line 
and error bars indicate mean ± SD of one representative experiment, N=1, 1way ANOVA, 
 50 
Tukey´s multiple comparisons test, *, p<0.05. (D) List of confirmed candidates. (E) Counter 
screen testing motility effect of RNAi on N2;Q35 worms. Motility was performed using 
swimming assay at day 5 of adulthood, N=1, 15 worms per condition, each dot represents 
one animal, line and error bars indicate mean ± SD of one representative experiment, N=1, 
1way ANOVA, Tukey´s multiple comparisons test, ns. (F) Quantification of aggregates of mir-
1;Q35 worms on RNAi against top candidates daf-16 and vha-13. Luciferase was used as 
control RNAi. Each dot represents one animal,error bars indicate mean ± SD, 1way ANOVA, 
Tukey´s multiple comparisons test, N=1, ns. (G) Quantification of aggregates of mir-1(gk276); 
daf-16(mu86);Q35 mutants compared to mir-1;Q35 mutants, N=3, each dot represents one 
animal,error bars indicate mean ± SD, t-test, *** p<0.0001. 
 
2.3 Mir-1 proteomics screen for downstream mediators of mir-1 
induced PQC improvement 
 
As a second approach to identify mir-1 regulatory targets in an unbiased 
manner, I performed TMT shotgun proteomics analysis comparing mir-1 mutants to 
wild-type worms on day 1 of adulthood. (Previous attempts to use SILAC labeling of 
the worms did not yield any useful data). Approximately 2000 proteins were identified 
in the various replicates.  With TMT labeling, PCA analysis did not show a separation 
of WT and mir-1 genotypes, perhaps reflecting the limited measurable changes 
induced by mir-1 mutation. Using a p-value of 0.05 as cutoff yielded 56 proteins as 
significantly upregulated in mir-1 mutants compared to wild-type (Figure 14a). GO 
term analysis did not yield any commonly regulated pathway, probably due to the 
small sample size (Figure 14b). Interestingly, though two of the significantly 
upregulated proteins were v-ATPase subunits (vha-10 and vha-19), one of which 
(vha-19) was also found in the informatic screen. Seven other vha subunits were also 
detected including vha-13, but expression levels were unchanged (Figure 14c).  
I performed another motility screen using RNAi against the significantly 
upregulated candidates from the proteomics analysis (Figure 14d). Using the circle 
test, I initially identified 6 candidates that reversed mir-1 motility and contained a mir-
1 binding site (Figure 14e). These included vha-19, ccdc-55/NRSP1, nrfl-
1/SLC9A3R1, apl-1/amyloid precursor protein, dtmk-1/deoxythymidylate kinase, and 
hsp-17.  
In the secondary screen that was carried out using the more laborious body bend 
motility assay, ccdc-55 and vha-19 could be further confirmed as top candidates 
(Figure 14f).  
Detecting two v-ATPase subunits and identifying vha-19 in both screens as 
top candidates strengthened the evidence of the v-ATPase playing an important role 
in mir-1 dependent regulation of proteostasis. Moreover, daf-16 is proposed as a 
regulator of v-ATPAse expression (Baxi et al. 2017). Therefore, we focused further 
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on the investigation of this pathway and used the services of sunybiotech to 
endogenously tag daf-16, vha-13 and vha-19. As endogenously tagging of vha-19 
led to a lethal phenotype, I focused on vha-13 and daf-16 for further analysis.  
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Figure 14. RNAi screen for upregulated proteins in mir-1 mutants compared to wild-
type identifies vha-19 as candidate for mir-1 mediated regulation of polyQ toxicity.  
(A) List of proteomics results showing gene name and logFC of upregulated candidates with 
p-value>0.05 in 5 BR of mir-1 vs N2. (B) String analysis of candidates listed in (A). (C) v-
ATPase subunits detected in proteomics including the respective p-value and logFC 
comparing mir-1 mutants to wild-type. (D) RNAi screen workflow using proteomics results 
(upregulated with p-value>0.05 in 5 BR of mir-1 vs N2 5 BR) with a total of 59 RNAi clones, 
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readout motility was tested using the circle test. Motility scored on day 8 of adulthood. (E) 
Candidates of screen; red indicates candidates containing mir-1 binding site. In total 6/16 top 
hits contained mir-1 binding site. (F) Validation of candidates of initial screen by swimming 
assay at day 8 of adulthood, 15 worms per condition, each dot represents one animal, line 
and error bars indicate mean ± SD of one representative experiment, N=1, 1way ANOVA, 
Tukey´s multiple comparisons test, *, p<0.05. 
 
2.4 Requirement of vha-13 and daf-16 for mir-1 induced PQC 
improvement  
 
Both daf-16 and vha-13 (kd) completely reversed the motility of mir-1;Q35 
mutants (Figure 15a) and are therefore most likely be involved in mir-1 dependent 
proteostasis regulation. Interestingly, overexpression of vha-13 under a muscle-
specific promoter in Q35 worms, recapitulated the improved motility seen in mir-
1;Q35 worms (Figure 15b). However, overexpression of vha-13 in the muscle of Q35 
worms did not affect aggregate number (Figure 15c), consistent with previous 
observations that the aggregate phenotype is difficult to modulate. 
 
2.5 Vha-13 3’UTR is regulated by mir-1 in cell culture 
 
These findings raise the question whether the regulation by mir-1 is direct or 
indirect. To address this, I turned to in vitro cell culture studies.  I cloned the C. 
elegans vha-13 3´UTR into PmirGLO, a vector used to study regulation of 3´UTRs by 
miRNAs in a cell culture system. Mir-1 overexpression was achieved by a mir-1 
overexpression construct, which increased the mature form of mir-1 by 1000-fold as 
measured by RT-qPCR (Figure 15d). PmirGLO construct and either empty vector 
control or the vector expressing mir-1 was co-transfected and firefly and renilla 
(internal control) expression was measured after 24 hours on a luminescence 
spectrometer. Overexpression of mir-1 suppressed the expression of firefly luciferase 
compared to renilla luciferase, suggesting that mir-1 directly regulates vha-13 3´UTR 
(Figure 15e).  
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Figure 15. Vha-13 might be directly regulated by mir-1 and muscle-specific 
overexpression of vha-13 improves motility of Q35 worms, but does not affect 
aggregate formation. Daf-16 knockdown reverses motility as well as aggregate 
phenotype of mir-1 mutants.  
(A) Motility of mir-1;Q35 transgenic worms grown on RNAi against vha-13, daf-16 and 
luciferase L4 on, motility scored at day 8 of adulthood using swimming assay, each dot 
represents one animal, >15 worms per condition, line and error bar indicate mean ± SD of 
one representative experiment, N=3, individual t-tests, ****, p<0.0001. (B) Motility of wild-type 
and mir-1 mutant animals expressing Q35::YFP and wild-type animals expressing Q35::YFP 
and myo3p::flag::mcherry::vha-13cDNA at day 8 of adulthood, measured by swimming assay. 
>15 worms per condition, each dot represents one animal, line and error bars indicate mean ± 
SEM of one representative experiment, N=3, 1-way ANOVA, Tukey´s multiple comparisons 
test, *, p<0.05. (C) Quantification of Q35::YFP aggregates using Image J at day 4 of 
adulthood, each dot represents one animal, >15 worms per condition, line and error bar 
indicate mean ± SEM of one representative experiment, N=3, 1way ANOVA, Tukey´s multiple 
comparisons test, *, p<0.05. D) qRT-PCR levels showing relative mir-1 levels normalized to 
U6 in HEK293T cells transfected with C2 plasmid expressing mir-1 or empty vector (EV) 
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control. (E) Quantification of luciferase assay showing firefly luciferase levels under the 
control of vha-13 3´UTR normalized to renilla luciferase in HEK293T cells co-transfected with 
C2 plasmid expressing mir-1 or empty vector (EV) control, shown mean +SEM, N=2, t-test, *, 
p<0.05.  
 
2.6 Mir-1 mutation derepresses mRNA levels of v-ATPase subunits 
during ageing 
 
MicroRNAs can regulate both mRNA and protein levels of their targets. If mir-
1 regulates v-ATPase subunits, then mir-1 loss would be predicted to derepress v-
ATPase mRNA expression. Because v-ATPase activity is suggested to decline with 
age (Hughes and Gottschling 2012), I first examined the expression of subunits 
during the ageing process. RT-qPCR analysis confirmed a decline in mRNA levels of 
v-ATPase subunits already at day 4 of adulthood in wild-type worms (Figure 16a). In 
contrast, mir-1 mutants maintained mRNA levels of v-ATPase subunits between Day 
1 and Day 4 of adulthood (Figure 16b). Although a modest decrease could also be 
observed in v-ATPase mRNA in mir-1 mutants, levels of the vha-13 subunit seem to 
be especially stable between day 1 and day 4 of adulthood (Figure 16b). In 
summary, at the onset of visible Q35 protein aggregates (day 4), the mRNA of v-
ATPase subunits was 2-fold increased in mir-1 mutants compared to wild-type 
worms (Figure 16c). To investigate whether mir-1 regulates our candidates on the 
protein level, we endogenously tagged daf-16, vha-13 and vha-19 by CRISPR/Cas9 
with either N-terminal 3xflag-tag (daf-16u) or 3xflag-neongreen-tag (vha-13u and 
vha-19u) (courtesy of Sunnybiotech). Tagging of vha-19 caused lethality, so I 
focused on daf-16 and vha-13. In addition, we mutated putative mir-1 binding sites in 
the 3´UTRs of daf-16 and vha-13 (daf-16um and vha-13 um) to see if this would 
affect expression levels (Figure 17a-c). Interestingly, I found that protein levels of 
vha-13 behaved similar to the mRNA, and were increased at day 4 of adulthood in 
mir-1 mutants relative to wild type. Notably Western blot analysis revealed that VHA-
13 protein levels were slightly increased in all 4 replicates in mir-1 mutants, though 
not reaching significance (Figure 16d). 
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Figure 16. v-ATPase subunits are downregulated with age in wild-type, but not mir-1 
mutants. (A) qRT-PCR showing levels of different v-ATPase subunits at day 4 normalized 
relative to day 1 in wild-type worms. V-ATPase subunits expression levels normalized to cdc-
42, shown mean +SEM, N=3. (B) qRT-PCR showing levels of different v-ATPase subunits at 
day 4 relative to day 1 in mir-1 mutant worms. V-ATPase subunits expression levels 
normalized to cdc-42, shown mean +SEM, N=3. (C) qRT-PCR showing levels of different v-
ATPase subunits in mir-1 mutants relative to wild-type at day 4 of adulthood. (D) 
Representative western blot showing vha-13u expression in mir-1 mutants and wild-type 
controls at day 4 of adulthood (E) Quantification of Western Blot analysis comparing protein 
levels of vha-13u in mir-1 mutants compared to wild-type controls at day 4 of adulthood, 
shown mean +SEM, N=4, individual t-tests, ns. 
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On the other hand, I saw no difference in expression of various daf-16 and 
vha-13 constructs by Western blot in WT and mir-1 backgrounds in day 1 adults, 
either at 20°C or 25°C (Figure 17 d-g), Nor did I observe regulation by mir-1 OE on 
the vha-13 reporter (Figure 17h). These findings suggest that there might be an age-
dependent regulation.  
 
Figure 17. Endogenously-tagged daf-16 and vha-13 protein level show no regulation by 
mir-1 on Day 1 of adult. 
daf-16u 3xflag 
3´UTR 
daf-16um 3xflag 
3´UTR 
vha-13u neongreen 3xflag 
3´UTR 
vha-13um neongreen 3xflag 
3´UTR 
flag::daf-16
Actin
   N2     mir-1   N2   mir-1
    N2    mir-1   N2   mir-1
da
f-1
6 /
 ac
tin
 
0.0
0.5
1.0
1.5
2.0
2.5
0.0
0.5
1.0
1.5
vh
a-
13
 / 
H
is
to
ne
N2 N2
flag::vha-13
Histone
0.0
0.5
1.0
1.5
da
f-1
6 
/ H
is
to
ne
N2 N2mir-1 mir-1
0.0
0.5
1.0
1.5
vh
a-
13
 / 
H
is
to
ne
N2 N2mir-1 mir-1
Ra
tio
 Fl
ag
 / 
H
ist
on
e
N2
 m
ir-1
 O
E N2
mi
r-1
 O
E
0.0
0.2
0.4
0.6
0.8
20°C
20°C
25°C
25°C
flag::daf-16
Actin
    N2    mir-1   N2   mir-1
flag::vha-13
Histone
     N2   mir-1   N2   mir-1
A CB
F
ED
flag::daf-16 flag::vha-13
Histone Histone
luci
daf-16u
daf-16u daf-16u
daf-16u
daf-16um
daf-16um daf-16um
daf-16um
vha-13u
vha-13u
vha-13u
vha-13u
vha-13um
vha-13um
vha-13um
vha-13um
daf-16u vha-13u
daf-16i luci vha-13i
G
H
N2 N2mir-1 mir-1
mir-1 mir-1
vha-13u vha-13um
wild-type mir-1 BS
mutated mir-1 BS
wild-type mir-1 BS
mutated mir-1 BS
 58 
(A) Schematic overview of strains made by sunybiotech. Endogenously N-terminally tagged 
daf-16 and vha-13 with wild-type (daf-16u/ vha-13u) or mutated (daf-16um/ vha-13um) mir-1 
binding site. (B) Western blot of total protein extracts of synchronized day 1 daf-16u 
transgenic worms incubated with anti-flag antibody grown on daf-16 or luciferase RNAi egg-
on. (C) Western blot of total protein extracts of synchronized day 1 vha-13u transgenic worms 
incubated with anti-flag antibody grown on vha-13 or luciferase RNAi L4 on. (D) 
Representative Western blot of total protein extracts of synchronized day 1 daf-16u and daf-
16um transgenic worms in mir-1 mutant and wild-type background incubated with anti-flag 
antibody, grown at 20°C egg-on (left). Quantification of Western Blot analysis showing 
flag::daf-16 levels normalized to actin, shown mean +SEM, N=3, t-test, ns (right).  
(E) Representative Western blot of total protein extracts of synchronized day 1  
daf-16u and daf-16um transgenic worms in mir-1 mutant and wild-type background incubated 
with anti-flag antibody, grown at 25°C egg-on (left). Quantification of Western Blot analysis 
showing flag::daf-16 levels normalized to actin, shown mean +SEM, N=3, t-test, ns (right). (F) 
Representative Western blot of total protein extracts of synchronized day 1 vha-13u and vha-
13um transgenic worms in mir-1 mutant and wild-type background incubated with anti-flag 
antibody, grown at 20°C egg-on (left). Quantification of Western Blot analysis showing 
flag::vha-13 levels normalized to histone, shown mean +SEM, N=3, t-test, ns. (G) 
Representative Western blot of total protein extracts of synchronized day 1 vha-13u and vha-
13um transgenic worms in mir-1 mutant and wild-type background incubated with anti-flag 
antibody, grown at 25°C egg-on (left). Quantification of Western Blot analysis showing 
flag::vha-13 levels normalized to histone, shown mean +SEM, N=3, t-test, ns. 
(H) Quantification of Western Blot of vha-13u vha-13um transgenic worms in the presence or 
absence of the mir-1 OE construct mir-1p::mir-1 on day 1 of adulthood grown at 20°C, 
normalized to histone, shown mean +SEM, N=3, t-test, ns. 
 
2.7 Tissue specific regulation 
 
The challenge to detect regulation of vha-13 by mir-1 using western blot is the 
ubiquitous expression of vha-13, while mir-1 most probably works in a muscle-
autonomous fashion. VHA-13 levels can be strongest observed in hypodermis, 
excretory cell, canal and gut (Figure 18a). vha-13 protein levels can also be 
measured in the pharyngeal isthmus, which is muscular tissue (Figure 18b). 
Interestingly, I observed that mir-1 mutants have increased VHA-13 protein level in 
the isthmus (Figure 18c+d), suggesting potential regulation. In line with regulation of 
VHA-13 by mir-1, overexpressing mir-1 decreased VHA-13 expression in the isthmus 
(Figure 18e). However, this regulation appeared to be independent of the mir-1 
binding site. It is possible that similar regulation might also take place in body wall 
muscle, but the expression levels were too difficult to determine because background 
from other tissues, especially hypodermis, masked the low expression in body wall 
muscle.  Both the tissue-specificity of mir-1 expression and the high expression of 
vha-13 outside of mir-1 expressing tissues explain why it is challenging to measure 
target regulation both by immunofluorescence and Western blot.  
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Figure 18. Mir-1 regulates vha-13 protein level in the isthmus 
(A) Representative confocal image showing expression pattern of vha-13u. Arrow indicate 
tissues that strongly express vha-13. G - Gut, H - Hypodermis, E - excretory cell, C - canal. 
(B) Close-up on pharynx of vha-13u, yellow circles mark the metacorpus (small circle) and 
the terminal bulb (large circle), where expression levels of vha-13 are low. White arrowheads 
indicate the isthmus, where expression of vha-13 is observed. (C) Representative picture of 
pharyngeal expression of vha-13 in wild-type and mir-1 mutant worms. Red box marks the 
isthmus. (D) Quantification of fluorescent intensity of the isthmus as in (C), each dot 
represents one animal, >15 worms per condition, line and error bar indicate mean ± SD of 
one representative experiment, N=3, t-test, **, p<0.01, ****, p<0.0001. (E) Quantification of 
fluorescent intensity of VHA-13::neongreen expression in the isthmus in wild-type and mir-1 
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OE worms, line and error bar indicate mean ± SD of one representative experiment, N=3, t-
test, *, p<0.05 
 
To overcome the problem of high expression in tissues other than the muscle, 
I sought to investigate vha-13 and daf-16 regulation in the muscle using tissue 
specific promoters. To do so, I first used a myo-3 driven daf-16 reporter strain 
containing the endogenous daf-16 3´UTR. Notably, DAF-16 protein levels were 
highly upregulated in mir-1 mutants compared to wild-type controls as measured by 
Western Blot analysis and microscopic imaging (Figure 19a). The upregulation was 
not due to a general increase in myo-3 transcription in mir-1 mutants as measured by 
RT-qPCR (Figure 19b). To further investigate whether this effect is due to a direct 
regulation by mir-1, I am currently mutating the binding site for mir-1 in the muscle-
specific daf-16 expressing plasmid. To further exclude a regulation of the 
extrachromosomal plasmid itself by mir-1, I performed Western Blot analysis using a 
strain expressing the myo-3 promoter plasmid only driving a GFP. No regulation was 
observed when comparing mir-1 mutants to wild-type controls (Figure 19c). To 
investigate muscle-specific vha-13 levels, I cloned vha-13 cDNA and its endogenous 
3´UTR into a myo-3p::mcherry::flag::HA expression vector and created an 
extrachromosomal line by microinjection. Using Western Blot technique, VHA-13 was 
observed at the estimated size and the band disappeared upon vha-13 RNAi (data 
not shown), confirming that vha-13 was expressed. When I compared muscle-
specific vha-13 expression in mir-1 mutants compared to wild-type controls, the 
construct was upregulated in mir-1 mutants. (Figure 19d+e). Interestingly, when I 
swapped the 3´UTR of the construct to unc-54 3´UTR, which lacks the mir-1 binding 
sites, the construct was no longer regulated in mir-1 mutants (Figure 19f+g). This 
suggests that mir-1 directly regulates vha-13 by binding to its 3´UTR. I also 
investigated the possible regulation of other predicted targets, like zyx-1, but could 
not observe any regulation of a zyx-1P::zyx-1::GFP reporter, further narrowing the 
pool of true targets that mediate the mir-1 dependent effect on PQC to vha-13 and 
daf-16 (Figure 19h). 
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Figure 19.  Muscle-specific daf-16 containing its endogenous 3´UTR is regulated in mir-
1 mutant background, whereas muscle-specific vha-13 without its endogenous 3´UTR 
cannot be regulated by mir-1. (A) Representative Western Blot of total protein extracts of 
synchronized day 1 myo3p::daf-16::GFP::daf-16 3´UTR transgenic worms in mir-1 mutant 
and wild-type background incubated with anti-GFP antibody (left). Representative pictures of 
muscle expression of myo3p::daf-16::GFP::daf-16 3´UTR transgenic worms in mir-1 mutant 
and wild-type background(right). (B) qRT-PCR showing relative mRNA levels of unc-54 and 
G 
D E 
F 
H 
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myo3 normalized to cdc-42 in mir-1 mutants compared to wild-type controls, shown mean 
+SEM, N=3, individual t-tests, ns. (C) Western Blot of total protein extracts of synchronized 
L4 and day 1 myo3p::GFP::unc-54 3´UTR transgenic worms in mir-1 mutant and wild-type 
background incubated with anti-GFP antibody. (D) Representative Western Blot of total 
protein extracts of synchronized L4 myo3p::mcherry::flag::HA::vha-13::vha-13 3´UTR 
transgenic worms in mir-1 mutant and wild-type background incubated with anti-flag antibody. 
(E)Quantification of Western Blot analysis showing flag::vha-13 levels normalized to histone, 
shown mean +SEM, N=2, t-test, *, p<0.05. (F) Representative Western Blot of total protein 
extracts of synchronized L4 myo3p::mcherry::flag::HA::vha-13::unc-54 3´UTR transgenic 
worms in mir-1 mutant and wild-type background incubated with anti-flag antibody. (G) 
Quantification of Western Blot analysis showing flag::vha-13 levels normalized to histone, 
shown mean +SEM, N=3, t-test, ns. (H) Quantification of Western Blot analysis showing zyx-
1::GFP levels in L4 and Day 1 adults in wild-type and mir-1 mutant worms, normalized to 
histone, shown mean +SEM, N=2, t-test, ns. 
 
2.8 mir-1 affects lysosomal biogenesis 
 
Although my data suggested regulation of v-ATPase subunit, vha-13, by mir-
1, regulation of this one gene was subtle and difficult to see above background. On 
the other hand, mir-1 target predictions indicate multiple subunits of the v-ATPase as 
potential regulatory targets. I therefore reasoned that mir-1 might more generally 
affect lysosomal structure and function. To test this hypothesis, I first used a lmp-
1p::lmp-1::GFP reporter strain. LMP-1 protein specifically localizes to the membrane 
of lysosomes and is therefore used as marker for lysosomal biogenesis (Hermann et 
al. 2005). Protein levels of LMP-1 were significantly increased in mir-1 mutants 
compared to wild-type control, as measured by Western blot analysis (Figure 20a,b). 
The v-ATPase hydrolyzes ATP to pump protons across the membrane to acidify the 
lumen of the lysosome (Beyenbach and Wieczorek 2006). I therefore asked whether 
mir-1 mutants affect the number of acidified lysosomes. Using Lysotracker Red, a 
dye that targets mild to strong acidic membranous structures such as lysosomes 
(Chazotte 2011), I observed an increase in staining intensity in mir-1 mutants (Figure 
20c,d). Due to technical limitations, lysotracker staining could only be observed in the 
worm intestine. This result leaves open the question as to whether lysosomes are 
also regulated in the muscle and whether mir-1, being expressed in muscle tissue, 
might have a non-autonomous effect. Nonetheless, the overall increase in lysosome 
biogenesis is consistent with the upregulation of lysosomal components, such as the 
v-ATPase subunits, and a possible cause of mir-1-dependent regulation of 
proteostasis.  
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Figure 20. mir-1 mutants present an increase in acidified lysosomes and increased 
lysosomal biogenesis. (A) Western Blot for lmp-1::GFP in wild-type and mir-1 mutants at L4 
stage. (B) Quantification of Western blot (like in (A)), N=3, line and error bars indicate mean ± 
SEM, t-test, **, p<0.01. (C) Representative images of lysotracker staining in wild-type and 
mir-1 mutants at L4 stage. (D) Quantification of lysotracker images using a predefined 
squared area approximately spanning the second to fourth gut cell. Quantification was 
performed using Image J. N=3, line and error bars indicate mean ± SEM of one 
representative experiment, t-test, **, p<0.01.  
 
2.9 Mir-1 affects autophagic flux 
 
One of the main functions of the lysosome is to promote autophagy through 
fusion with the autophagosome. Therefore, I measured autophagic flux using a 
transgenic reporter strain expressing GFP-tagged LGG-1. LGG-1::GFP associates 
with the inner and the outer membrane of the phagophore. While the LGG-1::GFP 
located in the outer membrane, is recycled to the cytosol, LGG-1::GFP attached to 
the inner membrane is degraded by lysosomal proteases. GFP is resistant to 
lysosomal pH and degrades more slowly. The ratio of free GFP to the sum of total 
GFP (free GFP and LGG-1::GFP) can be used to asses autophagic flux by Western 
Blot analysis (Lefebvre et al. 2014). In line with the increase in lysosomal mass, I 
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observed an increase in autophagic flux in mir-1 mutants compared to wildtype 
controls (Figure 21a,b). Starvation was used as control to confirm that the ratio of 
free GFP/total GFP is increased upon autophagy-inducing conditions. To further 
investigate whether the increase in autophagic flux is causative for the increased 
motility of mir-1 mutants, I knocked down components of the autophagy machinery in 
mir-1;Q35 worms by RNAi in order to rescue the motility phenotype. RNAi against 
autophagy components did not cause any toxicity as measured by knocking down 
essential autophagy genes in wildtype worms not expressing Q35. (Figure 21d). 
Despite variability, motility was modestly but significantly reduced in mir-1;Q35 
worms treated with RNAi against bec-1 and vps-33.1 (Figure 21c). Knockdown of v-
ATPase subunits caused a much more pronounced phenotype. V-ATPase 
knockdown is embryonal lethal and therefore I used RNAi treatment L4-onwards. 
RNAi against most autophagic genes does not cause embryonic lethality. For 
consistency, I used RNAi against autophagic genes L4 onwards instead of egg-on, 
which could have weakened the effect on motility even though worms were exposed 
to the RNAi for 8 days. RNAi clones were thus further tested for their ability to block 
autophagic flux using the above introduced LGG-1::GFP reporter strain. In this case, 
the ratio of GFP/total GFP was unchanged compared to luciferase control, sugesting 
the knockdown efficiency of autophagy genes might be insufficient to observe any 
interpretable results at least when RNAi was used L4-onwards (data not shown).  
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Figure 21. mir-1 mutants present an increase in autophagic flux.  
(A) Western blot of total protein extracts of synchronized young adult GFP::LGG-1 transgenic 
worms incubated with anti-GFP antibody. Starvation was induced by transferring worms to 
unseeded NGM plates for 4h and was used as positive control for the induction of the 
autophagy reporter. The cleaved GFP forms (around 28 kDa) correspond to the GFP 
degradation products in the autophagolysosome. To analyze autophagic flux, the ratios of 
free GFP to total GFP (lgg-1::GFP + free GFP) were calculated.  
(B) Quantification of Western Blot as in (A). N=2, line and error bars indicate mean ± SEM, 
individual t-tests, **, p<0.01, ***, p<0.001. (C) Quantification of mir-1;Q35 motility grown on 
RNAi against components of autophagy machinery L4 onwards. Motility was scored on day 8 
of adulthood using swimming assay, N=2, line and error bars indicate mean ± SEM, 1-way 
ANOVA, Dunnett´s multiple comparisons test,*, p<0.05. (D) Quantification of N2 motility 
grown on RNAi against autophagy machinery L4 onwards. Motility was scored on day 8 of 
adulthood using swimming assay, N=1, line and error bars indicate mean ± SEM, 1-way 
ANOVA, Dunnett´s multiple comparisons test. 
 
 
To conclude, I generated evidence that mir-1 regulates proteostasis through 
the regulation of lysosome biogenesis and autophagy. This effect might be mediated 
by mir-1-dependent regulation of daf-16 and vha-13, and possibly via other v-
ATPase subunits.  
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2.10 Non-autonomous regulation by mir-1 
 
The finding that muscle mir-1 regulates lysosomal acidification in the intestine 
of C. elegans made me wonder whether mir-1 might function cell non-autonomously. 
Non-autonomous actions of miRNAs are highly debated in the field (O’Brien et al. 
2018) (H. Scott 2017) (M. H. Sohel 2016) and it would therefore be interesting to 
shed some light on this controversially discussed topic. I formulated two hypotheses:  
Either mir-1 was secreted from muscle to intestinal tissue to directly regulate target 
mRNAs in the intestine or mir-1 was regulating factors in the muscle tissues, which 
indirectly affected gene expression in the intestine (Figure 22a). First, I aimed to 
exclude the possibility that mir-1 is autonomously regulating gene expression by 
simply being expressed in the intestine. To test this possibility, I used a reporter line, 
which expresses GFP under the control of the mir-1 promotor. This reporter solely 
showed GFP-expression in the body wall muscle and pharynx of C. elegans (Figure 
22b). To further exclude that mir-1 is expressed in the intestine of the worm, I also 
performed in-situ hybridization, to detect low abundant RNAs. As expected, a strong 
signal for mir-1 in the pharynx and body wall muscle could be observed (Figure 22c). 
Unfortunately, even after intensive optimization of the technique, I was not able to 
fully conclude whether the subtle staining in the intestine of the worms was a real 
signal or background staining. At the same time, Yoshiki Andachi and Yuji Kohara 
published a method on in-situ hybridization of miRNAs in C. elegans (Andachi and 
Kohara 2016). Due to the very weak and inconsistent staining in the intestine, 
Andachi et al. reported that it was more likely that the staining was an artifact 
(personal communication). Mir-1 seems to be specifically expressed in the muscle 
tissue of C. elegans, although I cannot fully exclude that mir-1 might be secreted to  
gut tissue. 
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Figure 22. Mir-1 is expressed in muscle tissue, but not gut tissue.  
(A) Model showing two possible mechanisms of target regulation in the gut by mir-1: 1. direct 
regulation 2. indirect regulation. (B) Representative pictures showing mir-1p::GFP transgenic 
worms at day 1 of adulthood under basal conditions, N=2. (C) Representative pictures of ISH 
analysis for detection of mir-1 (green) in day 1 adult worms, N=2.   
 
As another test to see whether mir-1 is secreted to the gut to directly regulate 
gene expression, I used a construct containing three copies of the seed sequence of 
mir-1 in the 3´UTR (provided by Dr. Christoph Geisen). The 3´UTR was fused to GFP 
under the control of the gut specific ges-1 promoter (Figure 23a). I injected the ges-
1p::GFP::3xseed construct into C. elegans and crossed the respective strain into mir-
1 mutant background. Western Blot analysis of the GFP signal showed a mild de-
repression of the construct in mir-1 mutants (Figure 23b).   
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Figure 23. A gut-specific reporter for mir-1 regulation seems to be regulated C. 
elegans. (A) Schematic overview of reporter plasmid showing GFP under the control of a 
3´UTR including 3 copies of mir-1 seed region expressed under ges-1 promoter. (B) Western 
Blot of total protein extracts of day 1 ges-1p::GFP::3´UTR 3x mir-1 seed transgenic worms in 
wild-type or mir-1 mutant background incubated with anti-GFP antibody, N=3 (left). 
Quantification of Western Blot showing GFP levels normalized to Histone, N=3, t-test, ns. 
 
Although this initial finding suggested that mir-1 might regulate gene 
expression non-autonomously, the effect was too mild for any interpretation and 
proper controls for this effect need to be carried out. I reasoned that other model 
organisms whose tissues are easier to dissect might allow me to address some of 
these issues more directly. Interestingly, RNAseq data of miRNAs in Drosophila 
melanogaster generated by the group of Prof. Linda Partridge showed that mir-1 was 
not only detected in muscle tissue (thorax), but also in the gut and in fat tissue of the 
flies (Figure 24a). This result was quite interesting as mir-1 was described to be 
specific for muscle tissue expression in D. melanogaster (Aboobaker et al. 2005). I 
confirmed the RNAseq results by RT-qPCR (Figure 24b) and obtained with the help 
of Dr. Carina Weigelt UAS-mir-1 flies that were crossed with a muscle-specific driver 
line (MHC-Gal4). Interestingly, overexpressing mir-1 under a muscle-specific 
promoter not only increased mir-1 levels in the thorax, but also in fat and gut tissue 
(Figure 24c). To exclude that this effect is due to a leakiness of the promoter, I 
overexpressed mir-210, a brain-specific miRNA (Figure 24d) under the same MHC-
Gal4 promoter and observed an increase of mir-210 in the thorax, but not in the gut 
(Figure 24e). Mir-210 levels in fat tissue were slightly above detection limits in MHC-
Gal4<UAS-mir-210 flies, raising the possibility of promotor leakiness in this tissue. I 
therefore dissected flies and checked MHC levels. In fat tissue and gut I could detect 
MHC expression levels slightly above detection limit (Figure 24f). At this point, it is 
difficult to resolve whether the slight expression of MHC in gut and fat tissue can 
account for the increase in mir-1 levels in these tissues in MHC-Gal4<UAS-mir-1 
flies.  
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To further investigate whether mir-1 was transported extracellularly, I 
extracted hemolymph of wild-type flies and determined whether mir-1 could be 
detected in the circulation of the flies. Interestingly, mir-1 levels could be detected in 
the hemolymph (Figure 24g, upper panel), suggesting that mir-1 was at least 
secreted and stably circulating in flies. To exclude that the mir-1 levels detected in 
the hemolymph resulted from sheared cells during the hemolymph extraction 
process, I checked for cellular components like actin and MHC in the hemolymph, 
which were both below detection limits and therefore not present in hemolymph 
(Figure 24g, lower panel).  
To conclude, we generated evidence that mir-1 is circulating in Drosophila 
hemolymph. Furthermore, we could show that mir-1 is present in tissues other than 
muscle tissue. However, whether mir-1 is regulating gene expression in a non-
autonomous fashion, either in a direct or indirect manner, remains to be seen.  
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Figure 24. mir-1 is detectable in Drosophila hemolymph and is increased in fat and gut 
tissue in flies overexpressing mir-1 under a muscle-specific promotor.  
(A) RNAseq Data provided by Linda Partridge shows mir-1 expression in muscle tissue 
(thorax) but also in fat and gut tissue. (B) Expression levels of mir-1 in head, thorax, fat and 
gut of wild-type flies as measured by TaqMan qPCR normalized to SnoR442, tissues 
extracted from 25 flies, N=1. (C) Expression levels of mir-1 in head, thorax, fat and gut of 
MHC-Gal4>UAS-mir-1 flies as measured by TaqMan qPCR normalized to SnoR442, tissues 
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extracted from 25 flies, N=1. (D) Expression levels of mir-210 in head, thorax, fat and gut of 
wild-type flies as measured by TaqMan qPCR normalized to SnoR442, tissues extracted from 
25 flies, N=2. (E) Expression levels of mir-210 in head, thorax, fat and gut of MHC-
Gal4>UAS-mir-210 flies as measured by TaqMan qPCR normalized to SnoR442, tissues 
extracted from 25 flies, N=2. (F) Expression levels of MHC in head, thorax, fat and gut of wild-
type flies as measured bei RT-qPCR normalized to actin, tissues extracted from 25 flies, N=1. 
(G) Expression levels of mir-1 in hemolymph of wild-type flies as measured by TaqMan 
qPCR, N=2 (upper table). Expression levels of MHC and actin in hemolymph of wild-type flies 
as measured by qRT-PCR, N=2 (lower table). 
 
3 Discussion 
In the following chapter I will conclude and discuss the findings of my PhD thesis.  
I present evidence that mir-1 decreases VHA-13 protein level by directly 
suppressing vha-13 mRNA in the muscle of wild-type C. elegans. This effect might 
be even more evident in the aged C. elegans. Mir-1 also decreases DAF-16 protein 
level in the muscle, possibly through a direct mechanism that still needs to be 
investigated. Downregulation of VHA-13 and possibly other v-ATPase subunits as 
well as DAF-16 decreases lysosomal biogenesis, lysosomal acidification and 
autophagic flux and manifests in polyglutamine aggregation and a decline in motility. 
Furthermore, I could provide evidence that mir-1 might act in a non-autonomous 
fashion.  
non-autonomous?
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Figure 25. Working Model. In wild-type worms, mir-1 represses vha-13 mRNA levels in the 
muscle of C. elegans, causing decreased VHA-13 protein levels. In a possible parallel 
pathway, mir-1 also represses DAF-16 protein level in the muscle of C. elegans. 
Downregulation of VHA-13 and possibly other v-ATPase subunits as well as DAF-16 
decreases lysosomal biogenesis, lysosomal acidification and autophagic flux and manifests in 
polyglutamine aggregation and a decline in motility (left). In 
 mir-1 mutants, vha-13 mRNA cannot be repressed by mir-1 and VHA-13 protein levels as 
well as DAF-16 protein levels are increased. Upregulation of VHA-13 and possibly other v-
ATPase subunits as well as DAF-16 increases lysosomal biogenesis, lysosomal acidification 
and autophagic flux and manifests in reduces polyglutamine aggregation and improved 
motility (right).  
 
3.1 Muscle ageing and mir-1 and its potential conservation 
 
Skeletal muscle is a major site of metabolic activity, accounting for about 40% 
of the total body mass, making it the most abundant tissue in the human body.  
Muscle ageing is described as a gradual decline of muscle mass and strength. 
Although the mechanism involved is only partially understood, it is thought that the 
accumulation of several events lead to muscle ageing. An accumulation of 
dysfunctional cellular components, especially mitochondria (Carter et al. 2018) (Mass 
et al. 2017), probably due to a decrease in cellular repair processes like autophagy 
and ubiquitin-proteasome pathway in combination with decreased protein synthesis 
of muscle proteins (Masiero et al. 2009) (Bonaldo and Sandri 2013) (Piccirillo et al. 
2014) play important roles in muscle ageing. Autophagy plays a crucial role in 
maintaining muscle mass (Masiero et al. 2009) (Escobar et al. 2019) as well as 
regenerative potential in geriatric satellite cells (García-prat et al. 2016). Recent 
reviews discuss autophagy as promoter of longevity (Hansen and Rubinsztein 2018) 
and as potential therapy to enhance aged muscle regeneration (David E. Lee et al. 
2019), highlighting the importance of this research.  
In my PhD, I identified the highly conserved muscle-enriched miRNA mir-1 as 
negative regulator of lysosomal biogenesis and autophagy. Mir-1 mutants were 
protected against polyglutamine- as well as human A-beta-induced paralysis, 
possibly via an upregulation of acidified lysosomes and an increase in autophagic 
flux. As I measured both, lysosomal biogenesis as well as autophagic flux only on 
day 1 of adulthood, I can not conclude whether both processes are also increased 
during the process of ageing or whether the protective effect against polyQ-induced 
proteotoxicity is rather due to an improved PQC only early in life. However, mRNA 
levels of v-ATPase subunits are maintained between day 1 and day 4 of adulthood in 
mir-1 mutants, whereas the levels dramatically decline in wild-type worms, 
suggesting a better functioning PQC network throughout the process of ageing in 
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mir-1 mutants. Further research is needed to investigate whether the autophagic flux 
and lysosomal biogenesis/acidification are also increased in ageing. As the 
maintenance of mRNA levels of several v-ATPase subunits in mir-1 mutants could 
potentially lead to an improved muscle health during ageing, it would be interesting to 
explore whether overall muscle health and function, including mitochondrial function, 
is increased in mir-1 mutants. I obtained preliminary evidence by showing that worms 
lacking mir-1 present a more juvenile posture and motility up to day 20 of adulthood 
when grown at 25°C. Further experiments focusing on muscle morphology and 
integrity are needed to strengthen the potential benefit of mir-1 deletion on muscle 
ageing.  
Whether mir-1 is upregulated in the aged human muscle, is controversial, because 
only few studies analyzed microRNAs in aged muscle tissue and the heterogeneity in 
human studies is problematic to identify small quantitative changes in tightly 
controlled pathways (Nielsen et al. 2014) (Jung et al. 2018). Nonetheless, mir-1 was 
recently reported as an interesting biomarker to measure frailty (Rusanova et al. 
2019). Furthermore, it is well established that mir-1 is downregulated upon exercise 
(Zacharewicz, Lamon, and Aaron 2013) in muscle and also in the circulation 
(Denham et al. 2018). Furthermore, autophagy declines in human skeletal muscle 
with ageing and this decrease contributes to sarcopenia, whereas exercise increases 
autophagy in skeletal muscle in older subjects (Park 2019). Given my results on the 
link between mir-1 and autophagy, mir-1 might be an interesting target to investigate 
in those studies. 
Based on this mammalian data, it would be interesting to investigate the effect of 
exercise on mir-1 levels in C. elegans to further understand the underlying 
mechanism of mir-1 regulation during physical activity and its impact on PQC. 
Monica Driscoll established C. elegans as a useful model organism to study 
exercise- She could show that acute swimming-induced changes in C. elegans share 
common features with some acute exercise responses that are reported in humans 
(Laranjeiro et al. 2017). Interestingly, adaptations like body wall muscle 
improvements in structural gene expression, locomotory performance and 
mitochondrial morphology occurred after multiple daily swim sessions. Adaptions to 
exercise not only occurred in muscle tissue, but also extended neuromuscular and 
intestinal healthspan and enhanced learning ability and protected against 
neurodegeneration (Laranjeiro et al. 2019). The molecular processes that mediate 
these system-wide exercise benefits, especially as applies to “off targets” that do not 
actively participate in training directly, remain poorly understood. Mir-1 would be an 
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interesting candidate to study in the regulation of exercise-induced autonomous as 
well as non-autonomous health benefits.  
In C. elegans, mir-1 is downregulated with age in wild-type worms (Lucanic et 
al. 2013)(Ibáñez-Ventoso et al. 2006). However, mir-796, a mir-1 family member in 
C. elegans is one of the most upregulated miRNAs in C. elegans ageing (Kato et al. 
2011). Although the group of Slack already suggested v-ATPase subunits as 
potential targets of mir-1/mir-796 (Kato et al. 2011), no studies investigated the 
regulation of the v-ATPase by mir-1 so far. Also, a possible link between mir-1 and 
autophagy is still unclear. Only recently, one study by Hua et al showed that mir-1 
inhibits autophagy related 3-mediated (ATG3) autophagy in a cell culture model 
(Hua, Zhu, and Wei 2018). This study could hint towards an evolutionary conserved 
mechanism of mir-1 regulating autophagy. 
In conclusion, I generated evidence that mir-1 regulates muscle PQC in C. 
elegans by regulating lysosomal biogenesis and thereby possibly affecting 
autophagic flux. Whether the data generated during my PhD is transferable to higher 
organisms still needs to be assessed but the strong effect on PQC regulation in the 
muscle by mir-1 in C. elegans and the conservation of the mir-1 binding sites in 
mammalian v-ATPase subunits suggests a possible conservation of this regulation in 
higher organisms. Finding interventions to modulate autophagy is of interest in 
ageing research (Hansen and Rubinsztein 2018) (David E. Lee et al. 2019) and mir-
1, being a potential therapeutic target could open up novel opportunities. 
 
3.2 Target regulation by mir-1 
 
MiRNAs regulate thousands of mRNAs by means of complementarity to 
sequences in the 3´UTR of the transcripts. Complete complementary of the miRNA 
to the mRNA leads to degradation of the mRNA transcript. However, in most cases, 
the homology of the miRNA to the mRNA is incomplete and causes only a partial 
inhibition of mRNA translation, leading to a much milder effect on gene expression 
(Filipowicz, Bhattacharyya, and Sonenberg 2008). It is therefore expected that most 
miRNAs cause subtle changes on gene expression, making it rather difficult to 
identify regulation of defined targets by miRNAs (Selbach et al. 2008). Therefore, I 
undertook two independent and unbiased approaches to maximize the chances of 
finding candidates. Bioinformatic target prediction analysis clearly showed a strong 
clustering of v-ATPase subunits that I confirmed as potential mediators for mir-1-
dependent PQC in my motility screen. Interestingly, proteomic analysis also identified 
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two v-ATPase subunits as significantly upregulated proteins in mir-1 mutants. This 
finding was quite unexpected as only 56 proteins were upregulated in mir-1 mutants 
compared to wild-type. Although, other v-ATPase subunits (including vha-13) were 
not changed in proteomics, detecting two subunits in the small set of changed genes 
made us confident that v-ATPase subunits could be targets of mir-1. Unfortunately, 
tagging of VHA-19, the most promising candidate, caused a lethal phenotype and 
could not be further investigated.  
The tissue-specific expression of mir-1 made it challenging to confirm the 
regulation of vha-13 and daf-16 by mir-1. However, I could confirm the de-repression 
of both candidates in the muscle of mir-1 mutants and furthermore, could provide 
evidence that mir-1 directly regulates vha-13. Exchanging the complete endogenous 
3´UTR against one without mir-1 binding sites (unc-54 3´UTR) completely abolished 
the regulation of vha-13 reporter by mir-1, while mutating the mir-1 binding site in the 
endogenous 3´UTR did not prevent regulation of the vha-13 reporter by mir-1. It is 
conceivable that cryptic mir-1 binding sites might be present in the vha-13 3´UTR 
that provide regulation even when the canonical site is mutated. Sequence analysis 
of the 3´UTR revealed at least one non-conserved, weaker binding site that we are 
currently mutating.   
Although vha-13 seems to be an interesting regulatory protein, being 
implicated in germline rejuvenation (Adam Bohnert and Kenyon 2017), I am 
speculating that mir-1 might also be involved in the regulation of other v-ATPase 
subunits. It has been reported that miRNAs tend to regulate clusters of biological 
processes (Ribeiro et al. 2019). A striking number of v-ATPase subunits contain at 
least one mir-1 binding site, which opens up the question whether mir-1 might 
orchestrate the expression of the whole class of v-ATPase subunits. Alternatively, it 
is conceivable that daf-16, another potential target of mir-1, could regulate the 
expression of v-ATPase subunits, since the group of Carvalho showed that daf-16 
directly enhances transcription of v-ATPase subunits by binding to their promoter 
region (Baxi et al. 2017). Further experiments are needed to investigate whether 
there is crosstalk between the targets daf-16 and vha-13 or whether they work in 
parallel pathways to regulate mir-1-dependent muscle PQC. Furthermore, whether 
daf-16 is a direct target of mir-1 still needs to be elucidated.  
Another interesting, yet puzzling finding in my PhD work is the organismal-
wide maintenance of v-ATPase mRNA levels in mir-1 mutants during the process of 
ageing, despite the tissue-specific expression of mir-1. Vha-13 mRNA levels seem to 
be in particular stable during the ageing process in mir-1 mutants. Furthermore, 
overall protein levels of VHA-13, (as measured by western blot of the endogenously 
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tagged protein), are slightly upregulated in mir-1 mutants at day 4 of adulthood, 
although on day 1 of adulthood, the regulatory effect on VHA-13 protein can only be 
observed in muscle tissue. Whether this effect can be attributed to an organismal-
wide improved PQC due to improved muscle health in the aged worms needs to be 
further investigated.  
Another interesting aspect that I did not focus on during my PhD work is the 
regulation of retrograde signaling at the neuromuscular junction by mir-1. Gary 
Ruvkun, Joshua Kaplan and John Kim reported that mir-1 alters muscle sensitivity to 
acetylcholine (ACh), by regulating the nicotinic acetylcholine receptors UNC-29 and 
UNC-63 in C. elegans. The same study could show that mir-1 also regulates 
retrograde signaling by regulating the muscle transcription factor MEF-2, which 
results in altered pre-synaptic ACh secretion (Simon et al. 2008). Furthermore, 
Richard Morimoto showed also in C. elegans that a moderate increase in 
physiological cholinergic signaling at the neuromuscular junction (NMJ) induces the 
calcium (Ca2+)-dependent activation of HSF-1 in post-synaptic muscle cells, resulting 
in suppression of protein misfolding (Silva, Amaral, and Morimoto 2013). 
Interestingly, the group or Morimoto further reported that increased acetylcholine 
(ACh) signaling causes a general imbalance in protein homeostasis in the 
postsynaptic muscle cells, thereby leading to the premature appearance of polyQ35 
aggregates in the muscle of C. elegans (Garcia et al. 2007).  
It is therefore conceivable that mir-1 could exert at least part of its function on muscle 
PQC by regulating neuromuscular communication.  
In conclusion, I generated evidence that vha-13 and daf-16 play important 
roles in mir-1 dependent PQC in the muscle. However, whether this effect is direct or 
indirect and whether other factors contribute to mir-1 dependent muscle PQC needs 
to be further investigated. 
 
3.3 Non-autonomous regulation by mir-1 
 
Small RNAs that function in a non-cell autonomous manner are becoming 
increasingly recognized as regulatory molecules with the potential to transmit 
information between cells or even organs (Sarkies and Miska 2014). 
During the course of my work, I made several observations that could be consistent 
with such cell-non-autonomous regulation by mir-1: 
First, due to technical limitations, lysotracker staining was only measurable in the gut 
of C. elegans and was surprisingly increased in the gut of mir-1 mutants. Second, 
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lmp-1::GFP level and autophagic flux seem to be increased ubiquitously and third, at 
least in middle-aged worms (day 4), v-ATPase subunits seem to be increased 
ubiquitously as well. 
These findings raise the question whether the muscle-specific mir-1 might regulate 
PQC non-autonomously.  
Several decades ago, it was already reported that plant small-interference RNAs 
(siRNAs), could spread from one part of the plant to cause gene silencing (PGTS) in 
another part of the plant (Voinnet and Baulcombe 1997) (Palauqui et al. 1997). While 
the mobility of siRNAs and its consequences are meanwhile well documented, less is 
known about the mechanisms underlying non-autonomous effects of other classes of 
sRNAs, such as miRNAs. Interestingly, miRNAs are not only present in the 
circulation (Weber et al. 2010) (Chen et al. 2008) (Cogswell et al. 2008), but 
circulating miRNAs are also reported to be immensely stable (Mitchell et al. 2008). 
This is attributed to the fact that many circulating miRNAs are found in vesicles like 
exosomes (Gallo et al. 2012), suggesting a regulated release process. Although 
some studies reported that circulating miRNAs can be taken up and even regulate 
gene expression in recipient cells, less is known about the process of uptake and 
whether there is a directed release or if miRNAs are randomly taken up by cells 
through endocytosis (O’Brien et al. 2018).  
C. elegans, being an easily dissectible model organism, could help to shed some 
light on the exact mechanism of miRNA secretion, uptake and gene regulation in 
recipient cells. 
Using a mir-1 translational reporter, I could show that mir-1 is indeed solely 
expressed in muscle tissue of C. elegans. However, although in situ hybridization 
showed an expected intense staining in body wall muscle and pharynx, I could 
neither include or exclude whether there might be traces of mir-1 present in the gut of 
C. elegans. In addition, the gut-specific reporter containing three strong mir-1 binding 
sites was visibly derepressed in mir-1 mutants, but quantitative analysis of 
fluorescence showed that the difference did not reach significance.  
Drosophila data revealed that mir-1 is circulating in Drosophila hemolymph, but it is 
not clear whether the elevated mir-1 levels found in gut and fat in MHC-Gal4>UAS-
mir-1 flies are due to leakiness of the promoter. 
In summary, despite several approaches, my attempts to decipher the possibility of a 
non-autonomous regulation in C. elegans by mir-1 were inconclusive due to technical 
limitations.  
However, given the fact that the muscle makes up about 40% of the body mass and 
that the muscle serves as a source of amino acids to be utilized for energy 
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production by various organs during catabolic periods, it is conceivable that overall 
improved muscle health in mir-1 mutants positively affects processes like the PQC in 
other tissues. In Drosophila, several studies showed that interventions like muscle-
specific upregulation of AMPK (Manley 2013; Stenesen et al. 2013) or mTOR (Patel 
and Tamanoi 2006) improves systemic stress responses and even lifespan 
(Stenesen et al. 2013). Furthermore, muscle-specific activation of FoxO/4E-BP 
signaling in Drosophila promotes proteostasis not only in muscle but also in other 
tissues such as brain, fat tissue and retina via a systemic decrease in 
insulin signaling and upregulation of basal autophagy (Demontis and Perrimon 
2010). How these effects are communicated between muscle and recipient tissues 
are not entirely clear. In C. elegans, it has even been observed that entire lysosomes 
can be transferred directly between tissues (Kaoru Yasuda et al. 2011) (Nussbaum-
Krammer et al. 2013). 
  In conclusion, I could show potential tissue non-autonomous effects of mir-1. 
However, whether the mir-1 mediated effect on gut lysosome levels is a direct or 
indirect effect needs to be determined. It is conceivable that the non-autonomous 
effect by mir-1 is due to improved PQC in the C. elegans muscle, which in turn may 
have a positive effect on organismal PQC. How this improved organismal PQC is 
communicated (if it is not mir-1 directly), is yet another challenging variable that 
would be exciting to investigate in future studies.  
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4 Future perspectives 
 
My results presented in this thesis open up a number of important questions, as 
discussed in the previous chapter. These questions could initiate interesting follow-
up experiments. In this final chapter, I would like to highlight some future directions.  
 
4.1 Analyzing muscle morphology in ageing mir-1 mutants 
 
In my PhD work, I showed that mir-1 deletion was highly beneficial in a muscle-
specific polyQ proteotoxicity model. Not only was the load of aggregates significantly 
decreased but motility was also maintained into high age when control animals were 
already completely paralyzed. As aggregating proteins are only one of the many 
causes of muscle ageing, it would be interesting to better characterize the overall 
health benefit of mir-1 loss/loss-of-function in the ageing muscle, independent of the 
polyQ model. A recently published book chapter and a review summarizing recent 
findings regarding age-related changes in C. elegans are outstanding resources for 
the age-dependent anatomical changes of C. elegans (Herndon, Wolkow, Driscoll & 
Hall 2017) (Son et al. 2019). Based on these resources, I would suggest the 
characterization of several aspects of muscle ageing; motility (without polyQ), muscle 
morphology, mitochondrial morphology in the muscle as well as muscle structural 
gene expression. A special focus should also be on autophagy and lysosomal 
acidification in aged mir-1 mutants to investigate whether they maintain their 
increased levels of autophagy and lysosomal biogenesis/acidification that I reported 
in young worms. Mitochondrial function and structure is known to decline with age 
(Kayo Yasuda et al. 2006) and it would therefore be interesting to investigate 
mitochondrial muscle physiology in mir-1 mutants. As it was described that muscle 
myofilaments may remain unaffected during ageing (Mergoud, Molin, and Solari 
2014), one could focus on measuring pharyngeal morphology and pumping rate as a 
measure of muscle health as it is described that pumping rate declines with age 
(Huang, Xiong, and Kornfeld 2004) and that sarcopenia can be observed in the 
pharynx of C. elegans (Chow et al. 2008). Moreover, the degree of sarcopenia 
correlates with muscle contraction as measured by pumping rate (Chow et al. 2008). 
Although I did observe a similar decline in pumping rate between mir-1 mutants and 
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wild-type worms until day 8 of adulthood, it would be interesting to include more 
timepoints and measure pumping rate beyond day 8.  
As exercise is reported to improve healthy muscle ageing, all the above-mentioned 
parameter should be investigated in exercised C. elegans. First of all, one would 
need to establish a regulation of mir-1 upon exercise and whether the presence or 
absence of mir-1 influences adaptation to exercise. Monica Driscoll established 
swimming as a useful physical activity that mimics endurance sports in humans 
(Laranjeiro et al. 2017). Furthermore, she could observe exercise-induced 
adaptations to muscle gene expression and mitochondrial morphology and even 
health improvements in tissues that do not actively contribute to physical activity, like 
neurons and gut (Laranjeiro et al. 2019). It is conceivable, that mir-1 might play a role 
in these adaptive responses to physical activity. 
In conclusion, studying different cellular and molecular parameters of the 
muscle in aged worms would help paint a better picture of muscle aging in worm in 
general, as well as the role of mir-1 in this.  
 
4.2 Confirming mir-1 targets and finding potential upstream regulator 
 
In my PhD work, I provided evidence that mir-1 directly regulates vha-13 in the 
muscle of C. elegans, by binding to its 3´UTR. This data is promising, but the 
expression levels of the reporter lines are not exactly the same, and the difference in 
regulatory ability could thus be attributed to the different expression levels, rather 
than the 3´UTR itself. Similarly, it could be argued that the expression levels of unc-
54P::vha-13::unc-54 3´UTR construct exceed the range of mir-1 regulatory capacity. 
While this is latter explanation is unlikely, since both constructs are expressed at a 
relatively low level compared to the highly abundant mir-1, it would be advisable to 
explicitly exclude this possibility by creating more independent lines with more similar 
expression levels. In addition, by including a co-injection marker that encodes for a 
fluorescent protein in another tissue I could normalize regulation to this internal 
control. Furthermore, assessing the levels of unc-54P::vha-13::vha-13 3´UTR and 
unc-54P::vha-13::unc-54 3´UTR transgenes in a C. elegans strain that 
overexpresses mir-1 could give further evidence for a direct or indirect regulation. 
Assessing why regulation of vha-13 by mir-1 is prevented upon exchange of the 
entire 3´UTR, while vha-13 can still be regulated when the mir-1 binding site is only 
mutated, would be another interesting follow-up experiment. To this end we are 
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currently mutating the non-conserved, cryptic binding site that we recently detected 
in the vha-13 3´UTR. 
 Furthermore, it would be interesting to investigate whether other potential 
targets are directly regulated by mir-1. As the most interesting other subunit, vha-19, 
cannot be endogenously tagged due to embryonic lethality, extrachromosomal lines 
could be generated. Vha-5, another subunit which is strongly expressed in the 
pharynx and contains mir-1 binding sites, is another interesting candidate. 
Endogenously tagged vha-5 is viable and is currently investigated as potential mir-1 
target. 
 Although I could show that a muscle-specific daf-16 transgene is de-
repressed in the muscle of mir-1 mutants, it is still unclear whether this regulation is 
direct or indirect and needs to be addressed.  
 
4.3 Molecular crosstalk and potential upstream regulators  
 
In addition, to studying direct targets of mir-1 it would be interesting to assess if there 
is also additional crosstalk between the targets themselves. Such crosstalk could 
exist between daf-16 and the v-ATPase subunits, given that daf-16 was shown to 
directly regulate v-ATPase subunits at the transcriptional level (Baxi et al. 2017). 
 In addition to crosstalk between putative downstream targets, it is also 
possible that different miRNAs modulate the effect of mir-1. In particular, it has been 
reported that the mir-1 family member mir-796 is one of the strongest upregulated 
miRNAs in aged C. elegans (Ibáñez-Ventoso et al. 2006). As both miRNAs belong to 
the same family and therefore share the same targets, the presence of mir-796 in 
mir-1 mutants could be compensating and thereby alleviating the full effect of mir-1 
deletion on target mRNA. Although the mir-1/mir-796 double mutant did not further 
decrease aggregate number nor further increase motility (data not shown), it would 
be of interest to assess whether the double mutant might further de-repress VHA-13 
or further increase lysosomal function, autophagic flux or even lifespan. 
 Finally, finding potential upstream regulators would be helpful to further 
complete the genetical pathway in which mir-1 regulates muscle PQC. RNAseq data 
from our lab suggests that mir-1 is downregulated in daf-2 mutants. Interestingly, 
activation of the insulin pathway was reported to downregulate the expression of mir-
1 in human skeletal muscle. (Granjon et al. 2009). Furthermore, mir-1 is dysregulated 
in the muscle in type-2 diabetes (Ducluzeau et al. 2001). It would therefore be 
interesting to further investigate daf-2 as upstream regulator of mir-1. 
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4.4 Inspecting a link between muscle PQC and overall organismal PQC 
 
Interestingly, I observed increased lysosomal acidification in the gut of mir-1 mutants. 
This finding, together with the systemic increase in lysosomal biogenesis and 
autophagy suggests a possible systemic effect of muscle-specific mir-1 deletion. 
Several studies showed that by increasing muscle health, systemic health is also 
improved and can prolong lifespan (Demontis and Perrimon 2010) (Manley 2013) 
(Stenesen et al. 2013) (Patel and Tamanoi 2006). Therefore, increased protein 
quality control in the muscle caused by de-repression of mir-1 targets could have a 
systemic effect on C. elegans health.  
The intestinal biomass is converted into Vitellogenin proteins throughout the 
ageing process, so that they finally make up 30% - 40% of total worm content 
(Ezcurra et al. 2018). Interestingly, my proteomics data showed a decrease in 
several vitellogenin proteins in mir-1 mutants. It would therefore be interesting to 
determine fat content as measure of gut ageing.  
Fertility as a measure for germline ageing or memory tests as measure for 
neuronal ageing could be assessed to address whether the healthspan effect in mir-1 
mutants is limited to gut health or whether it is rather a systemic effect. 
In addition to assessing whether mir-1 affects protein quality control outside of 
the muscle, it will be of interest to understand how such an increase is 
communicated towards other tissues. Mir-1 might act cell non-autonomously by 
being secreted to the gut and directly regulating intestinal gene expression. I 
provided some preliminary evidence for this hypothesis; but fully answering this 
question requires a battery of in vivo as well as in vitro experiments and well-
designed controls.  
Firstly, one could re-analyze the Drosophila tissue samples. So far, I could not 
exclude promoter leakiness as cause for elevated mir-1 levels in fat and gut tissue in 
Drosophila overexpressing mir-1 under a muscle-specific promotor. As it has been 
suggested that mostly the mature forms of miRNAs are secreted and found in 
circulation (M. Sohel 2016) (Bayraktar, Van Roosbroeck, and Calin 2017) (Sarkies 
and Miska 2014), one could measure levels of the mature versus the pri- or pre-
miRNA in the different tissues to determine whether the miRNA is transcribed in the 
tissue or might indeed be taken up from the circulation.  
Secondly, one could overexpress mir-1 in a cell system and measure whether 
mir-1 is detectable in the supernatant. If mir-1 is detectable in supernatant, one could 
 83 
further investigate whether mir-1 might be circulating in a particular form, like in 
exosomes. Furthermore, donor cells could be incubated with the mir-1-containing 
supernatant and intracellular mir-1 levels could be investigated by qRT-PCR. 
Expressing a mir-1 reporter in the donor cell line, could answer the question whether 
secreted mir-1 is able to regulate gene expression in recipient cells. 
Finally, the gut-specific promoter construct containing 3xmir-1 binding site 
could further be investigated. So far, I explored whether I could observe a de-
repression of the reporter in mir-1 mutants, showing a slight but not significant effect. 
I could perform the converse experiment, investigating whether muscle-specific 
overexpression of mir-1 can suppress the gut reporter. 
 
4.5 Conservation in mammals 
 
Ultimately, it would be interesting to investigate whether the findings of my PhD work 
are evolutionarily conserved. Based on alignment analysis, I found that the 
mammalian homolog of VHA-13, ATP6V1A, also contains mir-1 binding sites in its 
3´UTR. 
Furthermore, it has been shown that mir-1 directly regulates expression of ATP6V1A 
through its 3´UTR as measured by luciferase constructs expressed in a human 
cancer cell line (Peng et al. 2018), suggesting such conservation may exist. It would 
therefore be of interest to further investigate this link between mir-1 and v-ATPase 
subunits in mammals. For example by performing cell culture experiments, preferably 
in muscle cell lines (C2C12 cells) to address whether modulation of mir-1 expression 
by siRNA or overexpression affects the abundance of ATP6V1A, autophagic flux and 
lysosomal acidification.  
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5 Material & Methods 
5.1 Genetics and C. elegans handling 
 
5.1.1 Maintenance of C. elegans 
All strains were maintained at 20°C on nematode growth plates seeded with OP50 
strain of E.coli. The strains used in experiments were outcrossed at least 4 times to 
N2 Bristol strain, which was also used as control strain. 
To decontaminate the strains, worms were washed off the NGM plates and collected 
in a falcon tube with M9. After the worms settled, supernatant was removed and 
worms were bleached for 10 minutes shaking in bleach solution (sodium 
hypochlorite, potassium hydroxide and water) until worms completely dissolved and 
only eggs remained. Samples were washed at least two times with M9 buffer and 
eggs were transferred to fresh culture plates.  
 
5.1.2 Synchronization of worm population 
For all experiments, worms were synchronized using egglays. Gravid adult worms 
were transferred to fresh NGM plates and allowed to lay eggs for 4 hours. Worms 
were then removed and eggs were allowed to develop until L4, Day 1 or Day 4/5 
adults and collected as indicated elsewhere. Egglays were always performed in the 
mornings to account for circadian rhythm.  
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5.1.3 List of C. elegans Strains used  
 
Table 1. List of C. elegans strains  
N2 Bristol (wild-type) 
AA2508 mir-1(gk276) I 
AA4575 mir-1(dh1111) 
SJ4100 N2; zcIs13[hsp-6::GFP] V 
AA4404 mir-1(gk276); zcIs13[hsp-6::GFP] V 
SJ4005 N2; zcIs4[hsp-4::GFP] V 
AA4405 mir-1(gk276); zcIs4[hsp-4::GFP] V 
AM141 N2; rmIs133[P(unc-54) Q40::YFP] 
AA3112 mir-1(gk276) I; rmIs133[P(unc-54) Q40::YFP] 
AM140 rmIs132[P(unc-54) Q35::YFP] 
AA4403 mir-1(gk276); rmIs132[P(unc-54) Q35::YFP] 
AA4577 mir-1(dh1111);rmIs132[P(unc-54) Q35::YFP] 
AA4809 N2; rmIs132[P(unc-54) Q35::YFP]; dhEx965[mir-1p::mir-1, myo-
2p::mCherry] 
AA4810 mir-1(gk276); rmIs132[P(unc-54) Q35::YFP]; dhEx965[mir-1p::mir-1, 
myo-2p::mCherry] 
AA2794 N2; rmEx135(F25B3.3p::Q86::YFP) 
 
mir-1(gk276); rmEx135(F25B3.3p::Q86::YFP) 
CL2006 dvIs2[pCL12(Punc-54::human Abeta peptide 1-42 minigene; pRF4(rol-
6(su1006)) 
AA4811 mir-1 (gk276); dvIs2[pCL12(Punc-54::human Abeta peptide 1-42 
minigene; pRF4(rol-6(su1006)) 
 
daf-16(mu86);mir-1(gk276); rmIs132[P(unc-54) Q35::YFP] 
RT258 unc-119(ed3) III; pwIs50pwIs50[lmp-1::GFP + Cbr-unc-119(+)]. 
AA4812 mir-1(gk276);  pwIs50pwIs50[lmp-1::GFP + Cbr-unc-119(+)] 
AA4583 adIs2122(lgg-1::GFP; rol-6(su1006)) 
AA2532 mir-1(gk276) I; adIs2122(lgg-1::GFP; rol-6(su1006)) 
PHX506  daf-16(syb506) 
AA4808 mir-1 (gk276); daf-16(syb506) 
PHX502 daf-16(syb502) 
AA4807 mir-1 (gk276); daf-16(syb502) 
PHX586  vha-13(syb586) 
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AA4813 mir-1 (gk276); vha-13(syb586) 
PHX587 vha-13(syb587 syb504) 
AA4814 mir-1 (gk276); vha-13(syb587 syb504) 
AA4850 vha-13(syb586); dhEx965[mir-1p::mir-1, myo-2p::mCherry] 
AA4851 vha-13(syb587 syb504); dhEx965[mir-1p::mir-1, myo-2p::mCherry] 
AA2511 mir-1(gk276) I; daf-16(mu86) I; muEx212(myo-3p::GFP::daf-16; rol-
6(su1006)) 
AA2512 daf-16(mu86) I; muEx212(myo-3p::GFP::daf-16; rol-6(su1006)) 
AA4865 N2;Ex[myo3p::flag::HA::mCherry::vha-13cDNA::unc-54 3´UTR, 
my2p::GFP] 
AA4866 mir-1(gk276);Ex[myo3p::flag::HA::mCherry::vha-13cDNA::unc-54 3´UTR, 
my2p::GFP] 
 
N2;Ex[myo3p::flag::HA::mCherry::vha-13cDNA::vha-13 3´UTR, 
my2p::GFP] 
 
mir-1(gk276);Ex[myo3p::flag::HA::mCherry::vha-13cDNA::vha-13 3´UTR, 
my2p::GFP] 
PP1375 uthEx633(myo3p::GFP) 
AA4816 mir-1 (gk276); uthEx633(myo3p::GFP) 
AA3569 maIs251[unc-119(+) + Pmir-1::GFP] 
AA3939 N2; dhEx1176[daf-16 3´UTR-3xmir-1-si-pCF110+ myo-2p::mCherry] G3 
 
mir-1(gk276); dhEx1176[daf-16 3´UTR-3xmir-1-si-pCF110+ myo-
2p::mCherry]  
AA3569 maIs251[unc-119(+) + Pmir-1::GFP] 
AA4987 N2; rmIs132[P(unc-54) Q35::YFP; myo3p::flag::HA::mCherry::vha-
13cDNA::unc-54 3´UTR, my2p::GFP] 
 
5.1.4 Genotyping 
In case genotyping was not possible by phenotypic assessment, taq polymerase 
chain reaction (PCR) and agarose gel electrophoresis were conducted. As template 
served the lysate obtained from incubating a single worm in 10 μl (for PCR) single 
worm lysis buffer (10mM Tris pH 8.3, 50mM KCl, 2.5 mM MgCl2, 0.45% Tween 20, 
0.45% Triton X-100 (all v/v), 1mg/ml proteinase K (NEB)) for 60 min at 65°C and 
subsequently 15 min at 95°C.  
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Table 2. List PCR primer  
Genotype PCR primer PCR product 
mir-1 (gk276) FW 
CCGCATCGCGAAAAGTCATC 
RV 
CCAAATCTTTCACGAGTCGT 
WT: 500 bp 
MUT: 300 bp 
daf-16 (mu86) 
 
Source:  
Hansen, 2003 
Pr. 1 (MH39) 
CCGTTCAAGCTGCTGCCTTCACTCT 
PR. 2 (MH40) 
CAGCATCTTCTTCAGGAATTTGTTC 
Pr. 3 (MH41) 
GCCTTTGTCTCTCTATCGGCCACCA 
Pr. 4 (MH42) 
CGGAAAGATGATGGAACGTT 
 
WT: 473 bp 
MUT: 657 bp 
 
 
5.1.5 Gene knockdown by RNAi 
Worms were either grown egg-on or L4 onwards on E. coli HT115 (DE3) bacteria 
expressing dsRNA of the target gene under the control of an IPTG-inducible 
promotor. NGM plates for RNAi experiments contained a final concentration of 100 
μg/μl ampicillin and 1mM IPTG to select for vector carrying HT115 bacteria and 
induce dsRNA expression. All RNAi clones used for this thesis were selected either 
from the Ahringer or the Vidal library (Kamath and Ahringer 2003; Rual et al. 2004). 
All RNAi clones, except of excluded candidates from the RNAi screens were 
confirmed by sequencing. 
 
5.1.6 Lifespan assay 
Lifespan assays were either performed at 20°C or 25°C. N2 Bristol lifespan was used 
as control. Synchronization of worms was, as previously described, done by a 4h 
egglay. A minimum of 100 worms used per strain and transferred to fresh plates 
every day till the end of their reproductive period. Worms were scored every second 
day for their survival whereby worms that had undergone internal hatching or vulval 
bursting were censored. Data were plotted to calculate mean, median and maximum 
lifespan.  
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5.1.7 Brood size measurement 
Synchronized young adult worms were singled to 3 cm plates containing OP50. 
Worms were transferred to fresh plates every 24h and progeny was counted during a 
period of 5 days. A minimum of 10 worms were used for each genotype. 
 
5.1.8 Pharyngeal pumping rate assay 
Synchronized Day 1 worms were singled to 3 cm plates and pumping rate was 
measured by by counting grinder movements on a stereomicroscope on Day 1, Day 
4 and Day 8.  
 
5.1.9 Stress assays 
 
5.1.9.1 Heat stress 
Worms were grown to young adults under standard conditions. 50 worms were 
transferred to 6-cm NGM plates containing OP50 and exposed to 35°C for 8h. 
Survival was scored every 2h.  
 
5.1.9.2 Oxidative stress 
Worms were grown to young adults under standard conditions. Unseeded 3-cm 
plates were covered with 5 ul of a 1M H2O2 solution and plates were dried at room 
temperature. Final H2O2 was expected to be around 10mM. Worms were transferred 
to freshly prepared plates and scored every 2h. 
 
5.1.10 Worm imaging 
Standard worm maintenance was performed using a Leica M80 stereomicroscope. 
For analysing fluorescent intensity at a lower magnification, stacks of worms were 
aligned on unseeded, iced NGM plates and imaged on a Leica M165FC fluorescence 
microscope using a Leica DFC 3000G camera and Leica Application Suite.  
Images of single worms were either obtained on a Carl Zeiss Axio Imager Z1 
connected to a Zeiss Axiocam 506 mono camera using AxioVision software or on a 
Leica TCS SP8-X confocal microscope at 60 times magnification. Quantification of 
florescent intensity was determined using Adobe Photoshop CS5 (Microsoft office). 
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5.1.11 PolyQ aggregate quantification  
Quantification of polyQ aggregates of unc-54P::Q35::YFP worms were done from 
images obtained from synchronized Day 4 adults taken on a Leica M165FC 
fluorescence microscope (see 5.1.7) at a magnification of about 8 fold. Images of at 
least 15 worms were taken for each biological replicate. To avoid bias, worms were 
arranged for analysis on a Leica M80 light microscope. To further minimize bias, 
quantification of aggregates was done using Image J software. Images were inverted 
and the same threshold was used to subtract background. Image J particle analysis 
was then used to determine the number of aggregates per worm.  
 
5.1.12 Motility Assay 
 
5.1.12.1 Circle Test 
To assess motility in a swimming assay worms were synchronized to a 4 hours time 
window and were cultured at standard conditions on OP50, unless mentioned 
otherwise. A standardized circle was drawn on the bottom of unseeded NGM plates. 
Worms that were able to move at least slightly after touch stimulus on culture plates 
were transferred into the middle of the circled region. Worms that made it out of the 
circle within 1 minute were counted as mobile fraction. 
 
5.1.12.2 Swimming assay 
To assess motility in a swimming assay worms were synchronized to a 4 hours time 
window and were cultured at standard conditions on OP50, unless mentioned 
otherwise. Worms that were able to move at least slightly after touch stimulus on 
culture plates were transferred to M9 buffer on unseeded NGM plates and were 
allowed to adjust for about 30 sec. Body bends were then measured within a 30 sec 
interval by counting. 15 worms per genotype and condition were analyzed for each 
biological replicate. To avoid bias all experiments were carried out blinded.  
5.1.13 Fractionation of SDS soluble and SDS insoluble polyQ peptides 
Synchronized day 1 adult worms were harvested and washed in M9 and lysed in 
RIPA buffer (50 mM Tris pH 8, 150 mM NaCl, 5 mM EDTA, 0.5% SDS, 
1% NP40, complete Mini Protease and phosphatase Inhibitor Cocktail (Roche)) by 
freeze/thaw cycles and sonication. The insoluble fraction was pelleted by 20 min 
centrifugation at 4°C and 16,000 x g. The supernatant was subsequently collected as 
the soluble fraction and the pellet was washed in RIPA buffer and after centrifugation 
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solubilized in urea/SDS buffer (8 M urea, 50 mM Tris pH 8, 2% SDS, 50 mM DTT). 
4x LDS sample buffer (Thermo Fisher) was added to protein fractions and samples 
were separated and visualized by SDS PAGE and immunoblotting. 
To detect total amounts of SDS soluble and insoluble polyQ fragments worms were 
directly collected in urea/SDS buffer and snap frozen. 
 
5.1.14 Selective RNAi screen for bioinformatic and proteomics candidates 
Approximately 40 synchronized mir-1;Q35 worms were transferred L4 onwards to 
NGM plates containing 40 μM 5-Fluoro-2′- deoxyuridine (FUDR, Sigma), seeded with 
HT115 bacteria expressing select RNAi clones. Daf-2 RNAi was used as control that 
RNAi was properly induced, as knockdown of daf-2 is known to increase motility. At 
day 4 of adulthood worms were transferred to fresh culture plates and at day 8 
motility was assessed on plates by comparing to luciferase as well as polyQ in wild-
type background. Motility was tested on day 8 using the circle test described in (see 
5.1.9.1). RNAi clones that completely reversed mir-1;Q35 motility on luciferase back 
to Q35 motility on luciferase were selected as primary hits and were re-tested using 
the swimming assay and without FUDR in the culture plates (see 5.1.9.2). The effect 
of the candidate RNAi clones was next measured in polyQ in wild-type background 
as counter screen. The worms were grown to day 5 of adulthood and a motility assay 
was performed as described above. If the motility on specific RNAi clones was below 
the range of error of luciferase, the candidates were not considered secondary hits 
and excluded from further analysis.  
5.1.15 Microinjections 
N2 bristol strain was used for injections. L4 larvae were placed in a drop of about 50 
μl halocarbon oil (Sigma) on a 2% agarose pad. Injection Mix used to create 
myo3p::vha-13cDNA::unc-54 3´UTR extrachromosomal strains constisted of 40ng/ul 
of plasmid, 5 ng/ul of co-injection marker myo3p::GFP and 55 ng/ul of TOPO empty 
vector. Injections were done using a Carl Zeiss Axio Imager Z1 microscope installed 
with a manual micromanipulator which was connected to a microinjector (Femtojet4).  
 
5.1.16 CRISPR mir-1 alleles 
Design of CRISPR guides was done using services of http:://crispr.mit.edu/guides. 
NeBio sgRNA Designer was used to design primer. Engen sgRNA synthesis kit was 
finally used to synthesize guides. Guides were analyzed by gel electrophoresis and 
tape station. Injection mix contained the following components: Cas9 EnGen (NEB), 
mir-1 #3 sgRNA, mir-1 #6 sgRNA, mir-1 #9 sgRNA, mir-1 #10 sgRNA, dpy-10 
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sgRNA, KCl, Hepes pH 7.4, water. Mixture was incubated for 10 minutes at 37°C to 
allow activation of Cas9 and worms were injected as described in 5.1.11. In the F1 
generation worms with dpy phenotype were singled and genotyped for mir-1 deletion 
using mir-1 genotyping primer (table 2). 
 
Table 3. List CRISPR Guides 
Guide Name Target Sequence 
dpy-10 CGCTACCATAGGCACCACG 
mir-1 #3 AAGAAGTATGTAGAACGGGG 
mir-1 #6 GTAAAGAAGTATGTAGAACG 
mir-1 #9 TATAGAGTAGAATTGAATCT 
mir-1 #10 ATATAGAGTAGAATTGAATC 
 
5.2 Molecular Biology  
 
5.2.1 Molecular cloning 
All restriction digest reactions were performed with enzymes provided by NEB 
according to their user's manual. T4 DNA Ligase (NEB) was used for ligation 
reactions. Chemically competent DH5α Escherichia coli (LifeTechnologies) were 
used for transformation of ligation reactions or plasmids following the manufacturer’s 
instructions. For selection of positive clones, a suitable antibiotic was used, for 
example 100 μg/mL ampicillin in LB plates. To purify plasmids out of bacteria the 
QIAprep Miniprep or Midiprep Kits (Qiagen) were used. Cloning success was verified 
by PCR followed by gel electrophoresis and Sanger sequencing at Eurofins 
Genomics (Germany). Cloning strategies and primers used are described below 
(Table 4).  
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Table 4. Cloning strategy for vectors generated in this study including primers  
 
5.2.2 RNA extraction and quantitative RT-PCR  
Populations of about 500 day 1 and day 4 adult C. elegans were harvested in M9 
and washed twice in cold M9. The worm pellet was taken up in 700 μl QIAzol reagent 
(Qiagen) and snap frozen in liquid nitrogen. The samples were subjected to 4 
freeze/thaw cycles (liquid nitrogen/37°C water bath) and homogenization with 1.0 
mm Zirconia/Silica beads (FisherScientific) in a TissueLyser LT (Qiagen) for 15 min 
at full speed to crack the worms ́ cuticle and release RNA. After homogenization, 
supernatant was transferred to fresh eppendorff tubes and 120 μl Chloroform were 
added to 600 μl QIAzol solution. The components were mixed by vortexing and 
incubated for 2 min at RT. After 15 min centrifugation at 12000 x g and 4°C the 
aqueous phase was collected for total RNA extraction using the RNeasy Mini Kit 
(Qiagen) according to manufacturer’s instructions. The RNA quantitiy and quality 
were determined on a NanoDrop 2000c (peqLab) and cDNA was prepared using the 
iScript cDNA Synthesis Kit (BioRad). To quantifiy cDNA Power SYBR Green Master 
Mix (Applied Biosystems) was used and reaction was measured on a ViiA 7 Real-
Time PCR system (Applied Biosystems). Four technical replicates were pipetted on a 
384-well plate using the JANUS automated workstation (PerkinElmer). Expression of 
target RNA was calculated from comparative CT values, normalized to ama-1 and 
cdc-42 as internal controls using the corresponding ViiA7 software. All unpublished 
primers were validated by determination of their standard curves and melting 
properties.  
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Table 5. List quantitative RT-PCR primer  
ama-1 
FW 
GGATGGAATGTGGGTTGAGA 
RV 
CGGATTCTTGAATTTCGCGC  
cdc-42 
FW  
CTGCTGGACAGGAAGATTACG  
RV 
CTCGGACATTCTCGAATGAAG  
vha-5 
FW 
GCTCTTTCTCTTGCTCACGCTCA 
RV 
TCCGGTAACGAACACCATGTGC 
vha-10 
FW 
TGGCTGGAAACAAGCAAGCTGTC 
RV 
CTCGGCTTGATGTCGCAAACG 
vha-13 
FW 
AAGCTCTTCGTGAGATTTCTGGA 
RV 
ACGGATCCTTCACGTTCTGGAG 
vha-19 
FW 
AACAAGGCTTCGGCCAGTAATC 
RV 
GTCAACGGAGGCACTCTTATATG 
MHC 
FW 
GCAGAAGCGTCACAGCACTTCATTG 
RV 
AGTTGCTCGAAACCGTTGTACTC 
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Table 6. List Taqman Probes  
Target Gene Species Taqman Probe Number 
U18 C. elegans 001764 
mir-1 Human, Drosophila, C.elegans 000385 
SnoR442 Drosophila 001742 
mir-210 Drosophila 005997 
 
5.2.3 In-situ hybridization 
Populations of 5000 day 1 adults were harvested in PBS and washed twice with PBS 
before Fixation solution (PBS+4%PFA) was added to the worm pellet. Worms were 
fixed for 1h at room temperature shaking and subsequently washed twice with PBS 
and incubated in 70% EtOH overnight at 4°C. The next day, worms were washed 
twice with PBS and incubated with 1% H2O2 in PBS twice for 15 minutes to stop 
endogenous peroxidase activity. After three washing steps with PBST (PBS+0.1% 
Tween-20), worms were digested with proteinase K at a concentration of 20ug/ml in 
PBST for 20 minutes at 37°C. After washing twice with PBS, worms were dehydrated 
by emerging them in 70% EtOH for one minute, 96% EtOH for one minute, 99.9% 
EtOH for a minute. Worms were equilibrated in 1xISH buffer (Exiqon, #90000). 
Hybridization was performed by adding either 62 nM of mir-1-LNA probe or 
scrambled LNA control (Exiqon) in 1xISH buffer an incubating the worms for 2h at 
hybridization temperature of 44°C in a thermocycler. After hybridization, worms were 
washed in a dilution series of SSC buffer (Sigma): 5xSSC, 1xSSC and 0.2xSSC for 5 
minutes at hybridization temperature. After a last 5 minute incubation period of 
worms in 0.2xSSC buffer at RT, blocking solution (PBST+ 2% sheep serum+ 1% 
BSA) was added and incubated for 30 minutes at RT. Blocking solution was removed 
and anti-DIG-POD (1:400 in dilutant buffer) (Roche) was added and worms were 
incubated at RT for 1h. Worms were then washed twice with PBS-T for 3 minutes 
and twice with PBS for 3 minutes. For signal detection, worms were incubated in 
TSA-plus substrate (TSA Plus System, Perkin Elmer) for 10 minutes at RT.After 4 
washing steps of 5 minutes each in PBS, worms were finally mounted on a slide 
using SlowFade Gold antifade reagent with DAPI (Life technology) and kept 
overnight at RT in a dark box. The next day, worms were imaged on a Leica TCS 
SP8-X confocal microscope. 
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Table 7. List LNA microRNA probes 
MicroRNA Sequence Exiqon # 
cel-miR-1-3p 
miRCURY LNA 
miRNA  
 
5'UGGAAUGUAAAGAAGUAUGUA 
 
00614276 
 
Scrambled 
miRCURY LNA 
miRNA Control 
5’GTGTAACACGTCTATACGCCCA  
 
99004-15  
 
 
5.3 Biochemistry 
 
5.3.1 Proteomic analysis 
For sample collection, population of at least 5000 synchronized day 1 wild-type and 
mir-1 mutant worms were collected in M9 buffer, washed three times in M9 and 
directly frozen in liquid nitrogen and stored at -80°C until all 5 replicates were 
collected. Samples for proteomic analysis were then boiled in lysis buffer (100 mM 
Tris, 6 M Guanidinium chloride, 10 mM Tris(2-carboxyethyl)phosphine hydrochloride, 
40 mM 2-Chloroacetamide) for 10 min, lysed at high performance in 10 cycles of 30 s 
soncation intervals in a Bioruptor Plus sonication device (diagenode) and boiled 
again. The samples were centrifuged at 20000 x g for 20 min to get rid of debris. The 
samples were diluted 1:10 in 20 mM Tris pH 8.3 / 10% acetonitrile (ACN) and after 
the protein concentration was measured using BCA Protein Assays (Thermo Fisher) 
the samples were digested over night with rLys-C (Promega).The peptides were 
cleaned on a Supelco Visiprep SPE Vacuum Manifold (Sigma) using OASIS HLB 
Extraction cartridges (Waters). The columns were conditioned twice with Methanol, 
equilibrated twice with 0.1% formic acid, loaded with the sample, washed three times 
with 0.1% formic acid and the peptides eluted with 60% ACN / 0.1% formic acid. The 
samples were dried at 30°C for roughly 4 h in a Concentrator plus speedvac 
(Eppendorf) set for volatile aqueous substances. The dried peptides were taken up in 
an adequate volume of 0.1% formic acid (usually in 20 μl) and the samples were 
analyzed by the Max Planck Proteomic Core facility for analysis according to the 
following protocol (by Ilian Atanassov): 
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For protein identification and quantification, the raw data were analyzed with 
MaxQuant version 1.5.2.8 (Cox and Mann, 2008) using the integrated Andromeda 
search engine (Cox et al., 2011). Peptide fragmentation spectra were searched 
against the canonical and isoform sequences of the C. elegans reference proteome 
(proteome ID UP000001940, downloaded May 2017 from UniProt). Methionine 
oxidation and protein N-terminal acetylation were set as variable modifications; 
cysteine carbamidomethylation was set as fixed modification. The digestion 
parameters were set to “specific” and “Trypsin/P,” The minimum number of peptides 
and razor peptides for protein identification was 1; the minimum number of unique 
peptides was 0. Protein identification was performed at a peptide spectrum matches 
and protein false discovery rate of 0.01. The “second peptide” option was on. 
Successful identifications were transferred between the different raw files using the 
“Match between runs” option. Label-free quantification (LFQ) (Cox et al., 2014) was 
performed using an LFQ minimum ratio count of 2. LFQ intensities were filtered for at 
least four valid values in at least one group and imputed from a normal distribution 
with a width of 0.3 and down shift of 1.8. Differential expression analysis was 
performed using limma (Ritchie et al., 2015). Functional category annotation and 
enrichment analysis was performed using Perseus version 1.5.0.0 (Tyanova, Temu 
et al., 2016). The column “Majority protein IDs” was used for GOCC, GOBP, and 
GOMF annotation. Category enrichment analysis was done using Fisher exact test 
using an FDR threshold of 0.02.  
 
5.3.2 Western Blot analysis 
For Western blot analysis synchronized young adult or gravid day 1 adult worms 
were picked into eppendorf tubes containing M9, snap frozen in liquid nitrogen and 
lysed in 4x LDS sample buffer (Thermo Fisher) containing 50 mM DTT. After boiling 
and sonication, equal volumes were subjected to reducing SDS-PAGE and 
transferred to nitrocellulose membranes. The membranes were then blocked for two 
hours at room temperature in 5 % milk in Tris-buffered Saline and Tween20 (TBST) 
and probed with the primary antibodies in TBST with 5% milk overnight at 4 °C. 
Specific secondary antibodies (mouse or rabbit) were used at a concentration of 
1:5000 in TBST with 5 % milk at room temperature for two hours. The membranes 
were developed with Western Lightening Plus- Enhanced Chemiluminescence 
Substrate (PerkinElmer). Bands were detected on a ChemiDoc MP Imaging System 
(BioRad) and the intensity quantified using the corresponding Image Lab software 
(BioRad).  
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5.3.3 Antibodies 
The following primary antibodies were used in this study: GFP (JL-8 Living Colors, 
mouse monoclonal), Histone H3 (ab1791 abcam, rabbit polyclonal), α-Tubulin 
(T6199 Sigma, mouse monoclonal), FLAG (F1804 Sigma, mouse monoclonal).The 
following horseradish peroxidase conjugated antibodies were used in this study: anti-
mouse IgG (G-21040 Invitrogen, goat polyclonal), anti-rabbit IgG (G-21234 
Invitrogen, goat polyclonal).  
5.4 Drosophila work 
 
5.4.1 Maintenance of Drosophila 
Fly stocks were kept at 25°C on a 12h light and 12h dark cycle and fed a standard 1x 
SYA diet (5% sugar, 10% yeast, 1.5% agar, 0.3% Nipagen (10%in EtOH) and 0.03% 
Propionic Acid).  
 
5.4.2 Drosophila synchronization and dissection 
For all experiments, an equal number of eggs were distributed to new flasks to 
control for larval density. Females and males were allowed to mate for 48h (“once-
mated”) before each experiment. For dissections flies were first immobilizing by 
cooling them shortly on ice and subsequently tissues were dissected in phosphate-
buffered saline (PBS). Tissues were directly frozen on dry ice.  
 
5.4.3 Hemolymph extraction 
Hemolymph extraction was performed by cutting of the head of synchronized flies 
and placing them in a 0.5 ml eppendorf tube in which a small whole was poked in the 
bottom, just allowing liquid to pass. The eppendorf was then placed in a 1.5ml 
eppendorf tube and centrifuged at 10,000 rpm for 5 minutes.  
 
5.4.4 List of Drosophila strains used 
 
Table 8. List of Drosophila strains  
Name Source 
wDah Grönke et al. 2010 
MHC-Gal4 Partridge lab 
UAS-mir-1 Bloomington #41125 
UAS-mir-210 Partridge lab (Bejarano et al. 2012) 
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5.6 Cell Culture 
 
5.6.1 Luciferase assays 
HEK393T cells were seeded in a density of 5x104 cells per well in a 24-well plate. 
The following day, when cells reached >90% confluence, cells were transfected 
using Lipofectamine 2000. Cell were transfected either with 500 ng of PmirGLO-vha-
13 3´UTR and 250ng of pEGFP-C2 empty vector or 500 ng of PmirGLO-vha-13 
3´UTR and 250 ng of pEGFP-C2-hmir-1. Medium was changed 12h after transfection 
and transfection efficiency was assessed 24h after transfection using fluorescent 
microscopy. Cells were harvested after 24h and cell lysis was achieved rocking cells 
for 15 minutes in passive lysis buffer (provided in Promega Dual-reporter kit). A 
spectrometer that injected substrates automatically was used to determine signals of 
renilla luciferase and firefly luciferase. Firefly was measured after 1.5 seconds and 
renilla was measured after 15 seconds. Substrates were used from the Promega 
Dual-reporter kit. Controls were untransfected lysed cells for background and cells 
transfected with PmirGLO not containing any 3´UTR and either pEGFP-C2 empty 
vector or pEGFP-C2-hmir-1 to account for any regulation other than by the vha-13 
3´UTR. 
 
5.7 Statistical analysis 
Results are presented as mean + SD or SEM or mean ± SD or SEM as indicated. 
Statistical analyses were performed using 1way ANOVA with Tukey ́s or Dunnett ́s 
multiple comparisons test or unpaired t-test. The program used was GraphPad Prism 
(GraphPad software). Significance levels are *, p<0.05, **, p<0.01 and ***, p<0.001 
versus respective control. 
5.8 Software 
Most graphs were produced and statistical analyses performed using GraphPad 
PRISM 6.Data from proteomic experiments was graphically displayed using Instant 
Clue (Nolte et al., 2018). 
Bands on Western blots were quantified using Image Lab Software (Bio-Rad 
Laboratories GmbH).  
DNAstar software was used for in-silico cloning. 
ImageJ software was used for counting polyQ aggregates.  
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Supplementary Materials 
Table 9: Lifespan analysis, p-values for statistical analyses were calculated using Mantel-Cox 
Log Rank test. Worms that escaped the dishes, had internal hatching or had bursting of vulva 
were censored from the experiment. 
 
Strain/Treatment Median survival (days) Censored   Deaths Sig* Ref. Control 
      
20°C Lifespans           
N2 24 21         67 
  
mir-1 (gk276) 24 19 56 ns N2 
mir-1 (dh1111) 22 21 53 ns N2 
      
N2 20 7 115 
  
mir-1 (gk276) 23 1 127 ns N2 
      
25° Lifespans           
N2 15 4 77 
  
mir-1 (gk276) 15 5 91 ns N2 
mir-1 (dh1111) 17 1 72 0.0042 ** N2 
      
N2 15 3 45 
  
mir-1 (gk276) 17 3 52 ns N2 
mir-1 (dh1111) 17 3 48 0.0167 * N2 
      
N2 15 0 48 
  
mir-1 (gk276) 17 1 43 ns N2 
mir-1 (dh1111) 15 2 55 ns N2 
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Table 10: List of all genes tested in the bioinformatic-based selective RNAi suppressor 
screen for motility improvement 
 
Gene name Wormbase ID 
vha-1 R10E11.8 
ace-1 W09B12.1 
unc-44 B0350.2 
vha-14 F55H2.2 
vha-15 T14F9.1 
ifb-2 F10C1.7 
gly-13 B0416.6 
dpy-23 R160.1 
egl-46 K11G9.4 
let-363 B0261.2 
vha-8 C17H12.14 
egl-8 B0348.4 
vha-5 F35H10.4 
unc-11 C32E8.10 
vha-13 Y49A3A.2 
cwn-2 W01B6.1 
dyc-1 C33G3.1 
chs-2 F48A11.1 
syg-2 C26G2.1 
hyl-2 K02G10.6 
mlk-1 K11D12.10 
nac-3 K08E5.2 
pde-2 R08D7.6 
frm-8 H09G03.2 
sma-9 T05A10.1 
pkc-1 F57F5.5 
syd-2 F59F5.6 
unc-18 F27D9.1 
ncx-1 Y113G7A.4 
opt-3 F56F4.5 
kpc-1 F11A6.1 
alh-4 T05H4.13 
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tth-1 F08F1.8 
bar-1 C54D1.6 
glt-6 R05G6.6 
hpk-1 F20B6.8 
vha-9 ZK970.4 
daf-16 R13H8.1 
abts-3 F57F10.1 
sel-1 F45D3.5 
vha-12 F20B6.2 
grl-4 F42C5.7 
nep-1 ZK20.6 
sdn-1 F57C7.3 
lin-26 F18A1.2 
dhs-17 F29G9.6 
ras-2 F17C8.4 
vha-10 F46F11.5 
zyx-1 F42G4.3 
ncs-2 F10G8.5 
igcm-3 T02C5.3 
 
Table 11: List of up- or down-regulated genes and the respective logFC from proteomics 
analysis comparing mir-1 mutants to wild-type. candidates significantly (p<0.05) upregulated 
in mir-1 mutants compared to wild-type are highlighted in green. Candidates significantly 
(p<0.05) downregulated in mir-1 mutants compared to wild-type are highlighted in green. 
Upregulated genes were tested in the proteomics-based selective RNAi suppressor screen 
for motility improvement. 
 
Gene name logFC Gene name logFC 
cul-4 2,44 lsm-6 -2,75 
ccdc-55 1,41 perm-4 -2,47 
spt-4 1,39 tbc-14 -1,65 
asns-2 1,38 txdc-9 -1,61 
vha-19 1,36 vit-4 -1,50 
jmjc-1 1,00 vit-6 -1,42 
uri-1 0,93 nck-1 -1,41 
snr-5 0,90 heh-1 -1,35 
tni-1 0,78 ads-1 -1,30 
sut-2 0,70 nuo-4 -1,20 
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gyg-1 0,52 vit-2 -1,09 
ttr-26 0,45 col-106 -1,06 
pinn-4 0,45 art-1 -1,01 
hpo-18 0,42 dhs-9 -0,95 
valv-1 0,42 alh-12 -0,91 
zyx-1 0,40 prx-19 -0,88 
sams-4 0,39 ivd-1 -0,87 
dtmk-1 0,37 cysl-1 -0,81 
dss-1 0,37 gst-7 -0,78 
alp-1 0,36 hach-1 -0,76 
wrt-2 0,35 usp-14 -0,75 
aly-3 0,32 rack-1 -0,73 
unc-23 0,32 fat-2 -0,72 
klc-2 0,31 ttc-4 -0,62 
npp-16 0,30 pyr-1 -0,58 
mup-2 0,29 atn-1 -0,58 
set-26 0,29 rps-22 -0,55 
rnp-4 0,28 mlt-8 -0,55 
hpo-34 0,28 sca-1 -0,54 
nrfl-1 0,28 rps-9 -0,54 
pfd-4 0,27 aco-1 -0,52 
hsp-17 0,27 rps-7 -0,48 
vha-10 0,27 pck-2 -0,47 
hil-4 0,27 gta-1 -0,47 
snx-6 0,26 pyc-1 -0,46 
deb-1 0,25 fasn-1 -0,45 
hsr-9 0,25 rps-8 -0,44 
nex-1 0,25 cct-7 -0,42 
lmn-1 0,25 got-2.2 -0,41 
mrps-26 0,25 acdh-1 -0,41 
unc-87 0,25 gcn-1 -0,39 
pro-3 0,25 icl-1 -0,38 
irg-7 0,25 phb-2 -0,37 
afd-1 0,24 ogdh-1 -0,37 
col-71 0,24 hphd-1 -0,37 
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fubl-1 0,23 asna-1 -0,37 
frm-1 0,22 mrps-14 -0,33 
amph-1 0,21 ipgm-1 -0,33 
hmg-12 0,21 pccb-1 -0,33 
lec-3 0,21 alh-8 -0,32 
rbm-22 0,20 lap-2 -0,32 
nono-1 0,20 rpl-9 -0,32 
pfd-2 0,20 ctps-1 -0,30 
mua-3 0,20 vbh-1 -0,29 
rsp-3 0,17 rpl-33 -0,28 
npp-10 0,17 eif-3.B -0,28 
  
ttn-1 -0,28 
  
asp-1 -0,28 
  
gdi-1 -0,27 
  
rps-6 -0,27 
  
ketn-1 -0,26 
  
ech-6 -0,26 
  
hrp-2 -0,25 
  
mlp-1 -0,24 
  
spp-3 -0,24 
  
fah-1 -0,23 
  
unc-44 -0,23 
  
cth-2 -0,23 
  
fln-1 -0,22 
  
fbp-1 -0,22 
  
ttr-51 -0,21 
  
gln-3 -0,21 
  
lev-11 -0,20 
  
aco-2 -0,20 
  
rpl-10 -0,18 
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